ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000804.1|Acarviostatin_1 # 1 # 4860 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.683	BGC0000804.1|Acarviostatin_1 	1	4860	-	Loose	600	28.8758	clbB	31.34	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGAACCGCAGACATGGCGCGCACGGCGCCTCACGGAAGGCGGCCGCCGCAGCGGTCGCGGCGGCGCTGCTCGGCGCAGCGCTGCACACTGCCACGCCGGCTTCGGCGGCCCCGACACCGCCCAAGCCGCCCTCCGACGCGAAACTGGCCGCGGAGCCCGCACGCCATGATGTGACCCGCGAACAGTTCTACTTCGTCCTGCCCGACCGGTTCGCGAACGGGGACCGGTCCAACGACAGGGGAGGTCTCACCGGCAGCCGCTCGGTGACCGGATTCGACCCCACGGACAAGGGCTTCTACCAGGGCGGCGACCTCAAGGGCCTGACCCGGAAGCTCGACTACATCAAGGGCCTGGGCACCACCGCGATATGGATGGCGCCGATCTTCAAGAACAAACCGGTCCAGGGCAACGGCGAGAGCGCCGGATATCACGGCTACTGGATCACCGACTTCACCCGGGTCGACCCGCACTTCGGCACCAACCAGGACCTGAAGAACCTCGTCTCCAAGGCCCATGCCAAGGGTATGAAGGTCTACTTCGACGTCATCACCAACCACACCGCCGACGTCCTCACCAACACCGAGAAGAAGTACGGCTACCGGAGCAAGGGCGCCTACCCCTACCTCGACACCGAGGGCCGTCCGTTCGACGACACCGAGGAGACCGACCGCAAGGTCGACGAGGACTCGTTCCCCTACACGCCCCAGATCCCGGCTGCGGAGAAGACGGCCAAAGTCCCGGCGTGGCTGAACGACCCGACGATGTACCACAACCGCGGCGACTCGACCTTCGTCGGCGAGAGCGGCCTCTACGGCGACCACACCGGCCTGGACGATCTGTGGACCGAGCGGCCCGAGGTCGTCGAGGGCATGGAGAAGATCTACGAGAGGTGGGTCAAGGACTTCGACATCGACGGCTTCCGCGTGGACACCGTCCGCAACGTCGACATGAAGTTCTGGACGCAGTGGGCCACGGCCCTCGACGCCTACGCCGCCAAGCGGGGCCGGGACGACTTCTTCATCTTCGGTGAGACGCTCTCCGCCGACCCGTCCGTCATCGCCCCGTACGTGACCGAGGGCCGCCTCGACGCGACGCTCGACTTCCCGCTCCAGAACGCCATCCGCGGCTACGCCTCGCAGGGCAAGCCGGCCTCCGGCCTGTCGGACGTCTTCGCACAGGACTACCGGTACACCACGGACAAGGCCAACGCATACAACGAGGTCACGTTTCTCGGCAATCACGACATGGGCCGCATCGGCTCCTTCCTGAAGTCCGATCATCCGGGGGCCGGGGACGCGGAACTGTTGCGGCGAGACCGGCTGGCGCACGAGTTGATGTTCCTGTCGCGGGGCAACCCGGTGATCTACTCCGGCGACGAGCAGGGCTTCACCGGCGCCGGCGGGGACAAGGACGCCCGCCAGACGATGTTCGCGTCGAAGGTGGCGGACTACCTGGACGACGATGAGATCGGTACCAAGCGCACCCACGCGAGTGACGCGTATGACGTGCGGCATCCGCTGTACCGGTCGATCGCGGCGTTGTCGAAGCTGCGCAAGGCGAATCCGGCGTTGGCGGACGGGGTGCAGAAGGAGCTGTACGCGAAGGATTCCGTGTACGCGTTCTCGCGTACGGGGGGTGGCCGGGAGTATGTCGTCGCGGTCAACAACGCGAGTGCGGCGAAGACGGTCGAGCTGCCGGTGGAGAGTCGTGGGTCGGGCAAGTTCCGGTTCCTGTACGGCGGTTCGGGCAAGGTGCGGGCGAAGGATGGACGCATCGAGGTGACGGTGCCGGCTTTGTCGTCGGTGGTGCTGCGTGCGCAGAACAAGCTGAAGCGGCCGTCGGTGCGGCCGTCGGTGTCGCTGCAGGCGCCGGAGGCGGGTGCCACGGGCACGGTGACGATCTCGGCGGATCCGGGGCGGACGGCGGGTGCGCGGGTCGTCCTGGCCGCCCAGGTGGGCAACGGCAGATGGCAGACTCTCGGTTCCGCCGACCACGCTCCGTACAAGTTCACGCAGAAGATCCCCGACTCGGTGGCAGCCGGGACGTCTCTGCGCTACAAGGCCGTGGTGGTCGACCGTGCCGGCCGCACCGCGAGCACACTCGCCGACACCGTGACGGGGCAGGCACCGACGCCGAAGAAGCCGAGCGCCGTGGACCGCGCACACGCAGTCGTGCACTACAAGCGGGCGAACGGCGACTACGACAACGTCCTGCTCAAGTCCGGGGACACGGAAGCACGCTTCGTCGGCCGGGACGCCTACGGTGCCTTCGCCTGGGTGAGGGTTCCGGAGGGATCGGACTCGGTGACGTACACGATCGAGGACTCCGGCACGGCGGAGGGCGGCGAGCGCACCATCGACCTGGCGCAGACCGGTGAGGTCTGGGTCGAGCAGGGCAAGGAGGGTCAGGCGACCACCAAGCCGGACGGGGTGTACCCGTCCCCGGACAAGACGAAGGCGGTCATCCACGTCCACCGCTCCGACGGTGACTACGACGGATGGGGCCTGCACACCTGGACCGGCTCCGCCAAGGAGACGGACTGGACGAAGCCACTGCAGCCCGTCGGCAAGGATGCATACGGGGTCACCTTCGAGGTGCCGCTGTCCGACGGCGCGACCTCACTGAGCTACATCCTGCACAAGGGCGACGAGAAGGACATCCCCAGCGACCGGTCCCTGGACCTGGCCGTGTACGGCAACGAAGTCTGGCTGAACGCGGGGGAGAGCGGCTACTTGCTGCCCTCGGTCGGTTCGGCCCCGGACCTCGACATCACCAAGGCCCAGGCGCAGTGGATCGACACCGACACCGTTGCCCTGCCGCCCTCCATGAACGTCAAGGCCGCCGCGTCGACCCAGTTGGTGTACTCCCGCGACGGTGGCATCACCGTCGACGACGGCGCGCTCAGCAGCGAGGGGCGCTGGCTGCGGCTGCTGCCAGCGCAGCTCACCGAGTCCCAGAAAGCCGCGTATCCCCACCTGAAGGCGTACACGGCGTACACGGTCGACCCACGTGACCGGGACCGAGTGCGTGACGCCCTCTTCGGGCAGCTCATCCTGACCCAACGCCTCGCGAACGGTGCTCTGGCCACCGCGACCGGCGTCCAGATCCAGGGTGTCCTCGACGACGTGTACGCGGGGAAGGCGAAACGGACGGTGTTCGGGCCGGTGTTCAAGGGCCGCACCGCGTCCTTGACGGTCTGGGCACCGACGGCTCACAAGGTGTCCCTCGAACTCGACGGCAGAACCATCCCCATGCGCCGTGACGACGCGAGCGGCGCTTGGTCGGTGACCGGCCCCGCAGCCGCCTGGCGAGGCAAGGAGTACCGGTACGCGGTGACTGTGTGGGCACCCAGTGTCCAGAAGGTCGTCACCAACAAGGTCACCGACCCGTACTCCCTCGCCCTGACCACCGACTCCGAGCGCAGCCTCGTCGTCGACCTGGACGACCGCTCCCTCGCCCCGCGCGGCTGGGAGCACTACCGCAAGCCCGAGGCGGTGCCGCTCAGGGATGCCCAGATCCAGGAGCTGCACATCCGCGACTTCTCCGTCGCCGACCCGACGGCGGACGCGGACCACCGGGGCACCTACCTCGCCTTCACCGACGAGAAGAGCGACGGCTCGAAGCACCTGCGCGAGCTGGCCGGGGCTGGCACGTCCTACGTGCACCTGCTGCCCGCCTTCGACATCGCCACCATCCCCGAGAAGAAGTCCGAGCAGACGGTGCCCGGCTGCGACCTCGCCGCCTACCCGGCCGACTCCGAGAAGCAGCAGGAGTGCGTGACGAAGGCCGCCGCCAAGGACGCCTTCAACTGGGGCTACGACCCGTACCACTACACGGTCCCCGAGGGCTCCTACGCCACCGACCCCGACGGCACCGGGCGCACCGTCGAGTTCCGCAAGATGGTCAAGGCCCTCAACGACGACGGGCTGCGCGTCGTCATGGACGTCGTCTACAACCACACGGCCGCGAGCGGGACAGGCGAAGACCAGCGTCCTCGACCGGATCGTGCCCGGCTACTACCAGCGGCTGCTCGCCGACGGCTCGGTCGCCAACAGCACCTGCTGCTCCGACACGGCCACCGAGAACGCCATGATGGGCAAGCTCGTCGTCGACTCGGTCGTCACCTGGGCCAAGGAGTACAAGGTCGACGGCTTCCGCTTCGACCTCATGGGCCACCACCCCAAGGCCAACATCCTCGCGGTCCGCAAGGCGCTGGACGAGCTGACGCTCAAGAAGGACGGCGTCGACGGCAAGAAGATCATCCTGTACGGCGAGGGCTGGAACTTCGGCGAGGTCGCCGACGACGCCCGCTTCGTCCAGGCCACCCAGAAGAACATGGCCGGCACCGGCATCGCCACCTTCTCCGACCGGGCCCGCGACGCCGTGCGCGGCGGCGGCCCCTTCGACGAGGACCCCGGCGTCCAGGGCTTCGCCTCCGGCCTCTACACCGACCCCAACTCCTCGAAGGCCAACGGCACCGAGGCCGAGCAGAAGGCCCGCCTCCTGCACTACCAGGACCTGATCAAGGTCGGCCTGACCGGCAACCTCGCCGACTACGCCTTCACCGACACCGACGGCAAGGAGGTCAAGGGCTCCGAGGTCGACTACAACGGCGCCCCCGCCGGATACGCGGCGGCACCCGGCGACGCCCTCGCCTACGCCGACGCGCACGACAACGAGTCCCTGTTCGACGCGCTCGCCTTCAAGCTGCCCAAGGACACGTCCGCCGACGACCGGGCCCGCATGCAGGTCCTCGCCATGGCGACCGCCGCCCTCTCGCAGGGCCCGGCGCTGTCCCAGGCGGGCACCGACCTGCTGCGCTCCAAGTCGCTGGACCGCAACTCCTTCGACAGCGGTGA	MNRRHGAHGASRKAAAAAVAAALLGAALHTATPASAAPTPPKPPSDAKLAAEPARHDVTREQFYFVLPDRFANGDRSNDRGGLTGSRSVTGFDPTDKGFYQGGDLKGLTRKLDYIKGLGTTAIWMAPIFKNKPVQGNGESAGYHGYWITDFTRVDPHFGTNQDLKNLVSKAHAKGMKVYFDVITNHTADVLTNTEKKYGYRSKGAYPYLDTEGRPFDDTEETDRKVDEDSFPYTPQIPAAEKTAKVPAWLNDPTMYHNRGDSTFVGESGLYGDHTGLDDLWTERPEVVEGMEKIYERWVKDFDIDGFRVDTVRNVDMKFWTQWATALDAYAAKRGRDDFFIFGETLSADPSVIAPYVTEGRLDATLDFPLQNAIRGYASQGKPASGLSDVFAQDYRYTTDKANAYNEVTFLGNHDMGRIGSFLKSDHPGAGDAELLRRDRLAHELMFLSRGNPVIYSGDEQGFTGAGGDKDARQTMFASKVADYLDDDEIGTKRTHASDAYDVRHPLYRSIAALSKLRKANPALADGVQKELYAKDSVYAFSRTGGGREYVVAVNNASAAKTVELPVESRGSGKFRFLYGGSGKVRAKDGRIEVTVPALSSVVLRAQNKLKRPSVRPSVSLQAPEAGATGTVTISADPGRTAGARVVLAAQVGNGRWQTLGSADHAPYKFTQKIPDSVAAGTSLRYKAVVVDRAGRTASTLADTVTGQAPTPKKPSAVDRAHAVVHYKRANGDYDNVLLKSGDTEARFVGRDAYGAFAWVRVPEGSDSVTYTIEDSGTAEGGERTIDLAQTGEVWVEQGKEGQATTKPDGVYPSPDKTKAVIHVHRSDGDYDGWGLHTWTGSAKETDWTKPLQPVGKDAYGVTFEVPLSDGATSLSYILHKGDEKDIPSDRSLDLAVYGNEVWLNAGESGYLLPSVGSAPDLDITKAQAQWIDTDTVALPPSMNVKAAASTQLVYSRDGGITVDDGALSSEGRWLRLLPAQLTESQKAAYPHLKAYTAYTVDPRDRDRVRDALFGQLILTQRLANGALATATGVQIQGVLDDVYAGKAKRTVFGPVFKGRTASLTVWAPTAHKVSLELDGRTIPMRRDDASGAWSVTGPAAAWRGKEYRYAVTVWAPSVQKVVTNKVTDPYSLALTTDSERSLVVDLDDRSLAPRGWEHYRKPEAVPLRDAQIQELHIRDFSVADPTADADHRGTYLAFTDEKSDGSKHLRELAGAGTSYVHLLPAFDIATIPEKKSEQTVPGCDLAAYPADSEKQQECVTKAAAKDAFNWGYDPYHYTVPEGSYATDPDGTGRTVEFRKMVKALNDDGLRVVMDVVYNHTAASGTGEDQRPRPDRARLLPAAARRRLGRQQHLLLRHGHRERHDGQARRRLGRHLGQGVQGRRLPLRPHGPPPQGQHPRGPQGAGRADAQEGRRRRQEDHPVRRGLELRRGRRRRPLRPGHPEEHGRHRHRHLLRPGPRRRARRRPLRRGPRRPGLRLRPLHRPQLLEGQRHRGRAEGPPPALPGPDQGRPDRQPRRLRLHRHRRQGGQGLRGRLQRRPRRIRGGTRRRPRLRRRARQRVPVRRARLQAAQGHVRRRPGPHAGPRHGDRRPLAGPGAVPGGHRPAALQVAGPQLLRQR	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	472.01	gnl|BL_ORD_ID|109|hsp_num:0	127			786	987	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000804.1|Acarviostatin_2 # 4857 # 7985 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.674	BGC0000804.1|Acarviostatin_2 	4857	7985	-	Loose	600	32.3426	clbB	32.84	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGACCGGCTCTCTGCGAAGATCCGTTCTCACCACGGCGCTGGTGACCGTTCTGGCCACGGCCCTGCCCGCACCCGCGCACGCGGCGTCCGCACCCACGGCACCCGCGCCCCCACCCGACGCATGGCTGGCAGCGCAGCCCGCACGCCCTTCAGTGAGCAGGGAACAGTTCTACCTCCTCATGCCGGACCGCTTCGCGAACGCAGACCCGTCCAACGACCGAGGAGGCCTCAGCGGCGACCGCTACAGCACGGGCTACGACCCGACGGACAAGAATTTCTACCAGGGCGGCGACCTCAAGGGCATCACGCGCAGGCTCGACTACATCAAGGGACTGGGCACCACCGCGATCTGGCTCACGCCCGTGTTCCGCAACAAGACGGTGCTGGAACGGGGCGGCAAGAAGACCGCCTCCTATCATGGCTACGCCGTCACCGACTTCACCAGCGTCGACCCGCACTTCGGTTCGGAACGCGATCTCACCGACCTCATCTCCAAGGCCCATGCCAAGGGTATGAAGGTCTACTTCGACGTCATCACCAATCACACCGCCGACACCGTCGACTACGCGGAGAAGAAGTACGGCTACCGGAGCAAGGGCGCCTACCCGTACCTGGACGCGTCGGGCCAGCCCTTCGACGACGCCGAGGCCATGTCGAAGGTCGACCGGGACTCCTTCCCGTACACGCCGGAGAACACCGGCGAGATGGTCCCCGAGTGGCTGAACGACCCGACGATGTACCACAACCGCGGCGACTCGACCTTCGCCGGCGAGAGCGCGCTGTACGGCGACTTCTACGGCCTGGACGATCTGTGGACCGAGCGGCCCGAGGTCGTCCAGGGCATGGAGAAGATCTACGAGAAGTGGGTCGACGACTTCGACGTCGACGGTTTCCGCGTGGACACCGCCAAGAACGTCAACATGGAATTCTGGACGCAGTGGGCCACGGCACTCGACGCCTACGCCGCGAAGAAGGGCCGTGAGGACTTCTTCTTGTTCGCCGAGGCGTTCTCCGCCGACCCGGCCATCACCGCTCCCTACCTCACCGAGGGCCGCCTCGACGGAACTCTCGACTTCCCGCTCCAGTCCGCCATCCGCAACTATGCCTCACGAGGCGGCCCCGCCGGTGACCTGGCCACCGTCTTCGCGCAGGACTACCGGTACACCACGGACAAGACGAACGCGTACAGCCAGGTCACGTTTCTCGGCAGCCATGACATGGGCCGTATCGGCTTCTTCCTGAAGTCCGATCATCCGGGGGCCGGGGACGCGGAACTGTTGCGGCGGGACCGGCTGGCGCACGAGTTGATGTTCCTGTCGCGGGGCAACCCGGTGATCTACTCCGGTGACGAGCAGGGCTTCACCGGCGCCGGGGACGACGTCTACGGTCGTCAGTCGATGTTCGCGTCGAAGGTGGCGGACTACCTGGACGACGACGAGATCGGTACGGAGCGTACGCATGCGAGTGACGCGTATGACGTGCGGCATCCGCTGTACCGGTCGATCGCGGCGTTGTCGAAGCTGCGCAAGGCGAATCCGGCGTTGGCGGACGGGGTGCAGAAGGAGCTGTACGCGGGGGATTCCGTGTACGCGTTCTCGCGTACGGGGGGTGGCCGGGAGTATGTCGTCGCGGTCAACAACGCGAGTGCGGCGAAGACGGTCGAGCTGCCGGTGGAGAGTGCCGGATCGGGCAAGTTCCGTGTCTTGTACGGCGGTTCGGGCAGGGTGCGGGCGAAGGACGGGCGCATCGAGGTGACGGTGCCGGCTTTGTCGTCGGTGGTGCTGCGTGCGCAGAACAAGCTGAAGCGGCCGTCGGTGCGGCCGTCGGTGTCGCTGCAGGCGCCGGAGGCGGGTGCCACGGGCACGGTGACGATCTCGGCGGATCCGGGGCGGACGGCGGGTGCGCGGGTCGTCCTGGCCGCCCAGGTGGGCAACGGCAGATGGCAGACTCTCGGTTCCGCCGACCACGCTCCGTACAAGTTCACGCAGAAGATCCCCGACTCGGTGGCAGCCGGGACGCCTCTGCGCTACAAGGCCGTGGTGGTCGACCGTGCCGGCCGCACCGCGAGCACACTCGCCGACACCGTGGCGGGGCAGGCACCGACGCCGAAGAAGCCGACGGCCGAACGCCGCCACGTCGTCGTGCACTACCACCGCGCCGACGGCGACTACACCGGCCTGACGCTGCACACCGCGAACGGGACCACCGCCGACTTCTCGGGACGGGACGCCTACGGAGCGTTCGCATGGCTCAGCCCCGCGGAGGGGACCGGGAAGATCCGATTCACGGTCGAGCGTGACGGTAAACCCGAAGGCGCCGAGCGTGTCGTGGACGTCGCCGCGGCCGGTGAGGTATGGACGAAGGAGAACGCGGACCTCGTGGACGCCGTCCGTCCCGCGGACGCCTATCCACCTCAGGACACGACGAAGGCCGTCCTCCACTACCACCGTCCGGACGGCGACTACGCCGGCTGGGGCTTGCACACCTGGACCGGAGCCGCGAACCCGTCCGAGTGGAACGAACCGATCCAGCCGGTACGCCGCGACGCCTACGGTCTCGTATTCGAAGTGCCTCTCAAAGCGGGTGCGCCTTCCCTGAGCTACGTCTTCCACAAGAAGGAAGAAAAGGACGTCCCGGCCGACGAGGCACTTGTCTTCTCCTTGTACGGCCACGAGGTGTGGCGCGTCGCGGGCGAGGCGCCCTATCTGACGCCGTCCCTCGGCGGTGCCTTCCCGATGGATCTCGATCCCGCGGCCTCCGCGGCCACTTGGATCGACGAGAACACCGTCGTGTGGCACGGCACCGGCACGGGCGTCGCCGCCCAGCAACTCGTCTACGCCGCGGACGGGGGTCTGACTCTGCGGGACGGCGTCCTGTCCGACGAAGGGCAGTGGCTACGTCTCGTCCCCACCGAGCTGAGCGCGGCTCAGCAGGCGGCGCACCCCGAACTCGCCGACACCACGGCGTTCTCCATCGACCCGCGCGACCGCGACCGCATCCCCGAAGCACGCCGGGCCAAGCAGCTCATCGCCACCCAACGTTCCGACAACGGAGCTCTGTTGGGTGCAACGAGCGTGACAGCACTGTTCTCCACGCCCCAGCATGTCCAGAAGGGTTCGACCAGGTGA	MTGSLRRSVLTTALVTVLATALPAPAHAASAPTAPAPPPDAWLAAQPARPSVSREQFYLLMPDRFANADPSNDRGGLSGDRYSTGYDPTDKNFYQGGDLKGITRRLDYIKGLGTTAIWLTPVFRNKTVLERGGKKTASYHGYAVTDFTSVDPHFGSERDLTDLISKAHAKGMKVYFDVITNHTADTVDYAEKKYGYRSKGAYPYLDASGQPFDDAEAMSKVDRDSFPYTPENTGEMVPEWLNDPTMYHNRGDSTFAGESALYGDFYGLDDLWTERPEVVQGMEKIYEKWVDDFDVDGFRVDTAKNVNMEFWTQWATALDAYAAKKGREDFFLFAEAFSADPAITAPYLTEGRLDGTLDFPLQSAIRNYASRGGPAGDLATVFAQDYRYTTDKTNAYSQVTFLGSHDMGRIGFFLKSDHPGAGDAELLRRDRLAHELMFLSRGNPVIYSGDEQGFTGAGDDVYGRQSMFASKVADYLDDDEIGTERTHASDAYDVRHPLYRSIAALSKLRKANPALADGVQKELYAGDSVYAFSRTGGGREYVVAVNNASAAKTVELPVESAGSGKFRVLYGGSGRVRAKDGRIEVTVPALSSVVLRAQNKLKRPSVRPSVSLQAPEAGATGTVTISADPGRTAGARVVLAAQVGNGRWQTLGSADHAPYKFTQKIPDSVAAGTPLRYKAVVVDRAGRTASTLADTVAGQAPTPKKPTAERRHVVVHYHRADGDYTGLTLHTANGTTADFSGRDAYGAFAWLSPAEGTGKIRFTVERDGKPEGAERVVDVAAAGEVWTKENADLVDAVRPADAYPPQDTTKAVLHYHRPDGDYAGWGLHTWTGAANPSEWNEPIQPVRRDAYGLVFEVPLKAGAPSLSYVFHKKEEKDVPADEALVFSLYGHEVWRVAGEAPYLTPSLGGAFPMDLDPAASAATWIDENTVVWHGTGTGVAAQQLVYAADGGLTLRDGVLSDEGQWLRLVPTELSAAQQAAHPELADTTAFSIDPRDRDRIPEARRAKQLIATQRSDNGALLGATSVTALFSTPQHVQKGSTR	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	303.79	gnl|BL_ORD_ID|109|hsp_num:0	127			786	987	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000804.1|Acarviostatin_3 # 8099 # 9796 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.682	BGC0000804.1|Acarviostatin_3 	8099	9796	-	Loose	400	26.1794	catB9	28.07	3002681	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGCCAGAAAGTCCGTGGCTGCCGCACTCGCCGTCGTGGCGGGAGCCGCTGCCGCCGTCACGGTCCCGGCCCCGGCGCAGGCCGCGCCGGTCGGAGACAAGGACGTCACCGCGGTGATGTTCGAGTGGAACTTCGCATCGGTTGCCAAGGAGTGCACCGACACGCTCGGCCCCGCCGGCTACGGCTACGTCCAGGTCTCACCGCCCAACGAGCGGGTGCAGGGCAGCCAGTGGTGGACCGCCTACCAGCCGGTCAGCTACAAGATCGCCACCCGGCTCGGTGACCGCGCCGCGTTCAAGAGCATGGTCGAGACCTGTCACGCGGCCGGAGTGAAGGTCGTGGCCGACACCGTCATCAACCACATGGCCAACTCCTCCGGCACGGGTACCGGCGGCTCCACGTACAGCAAGTACGACTACCCGGGCACCTACTCCGGCGCGGACATGGACGACTGCCGCACCGACATCACCGATTACCGGGACCGCTGGAACGTCCAGCACTGCGAGATGGGCAGTCTGCCCGACCTCGACACCGGCGAGGAGTACGTCCGGAAGACCATCGCAGGGTACCTGAACGACCTGCTCTCCCTGGGCGTCGACGGATTCCGCGTCGACGCCGCCAAGCACATCGCCGTCGACGATCTCAAGGACATCAAGTCGCGGCTCACCGACCCGAACGCGTACATGAAGCTGGAAACGATCGGAGCCCCGGGGGAGGCCGTGCAGCCCAGTGAGTACCTGGGCGTCGGCGACCCGCAGGAGTTCACGTACGCCTATGATCTCAAGCGGGTCTTCAGCGGCGAGAAGCTCGCGTACCTGAAGAACTTCGGGGAGGACTGGGGGTACCTGCCGAGCGACAAGGCGTCCGTGTTCGTGACCAACCACGACACCGAACGCAACGGCCGGACGCTCACCTACAAGGACGGCGCCACGTACACGCTCGCCCAGGTCTTCTCGCTGGCCTGGCCGTACGGAGCTCCGGACGTGCACTCCGGCTACTCCTTCACCGACACGGCGGCGGGCGGCCCCAACGGCGGCCAGGTGAACGCCTGCTACACCGACGGCTGGAAGTGCCAGCACGCCTGGCGCGAGGTCGCGAGCATGGTCGCCTGGCGCAACACCGCCCACGGCGAGGCCGTGACGGACTGGTGGGACAACGGGAACAACCAGATCGCCTTCGGCCGCGGATCCAAGGCGTACGTCGCCATCAACCACGAGGGCGGATCGCTGACCCGCACGTTCCAGACCTCCCTGCCCGCCGGTGACTACTGCGACGTGCAGAGCGGCAAGGGCGTCACGGTGAACTCCGCCGGCCAGTTCACGGCCACGCTCGGGGCGAACACCGCGCTGGCCCTGCACGTCGGTGCAAAGACCTGTGGTGGCGGCAGCACCGACCCCGAGCCGGCCGCCGGCGCCTCGTTCCGCGTGAACGCCACGACCAGCTGGGGCGAGAACATCTACGTCACCGGCGACAACACCCGGCTCGGCGACTGGAACCCCGACAACGCACTCAAGCTCGACCCGGCCGCCTACCCGGTCTGGAAGCTCGACGTCAGCCTCCCGGCCGGGACCTCCTTCGAGTACAAGTACCTGCGCAAGGACGCGAACGGCAAGGTCACCTGGGAGAGCGGCGCGAACCGCACCGCGACCGTCTCGTCGTCAGGCACCGTCGTGCTCGGCGACACCTGGCGCGACTGA	MARKSVAAALAVVAGAAAAVTVPAPAQAAPVGDKDVTAVMFEWNFASVAKECTDTLGPAGYGYVQVSPPNERVQGSQWWTAYQPVSYKIATRLGDRAAFKSMVETCHAAGVKVVADTVINHMANSSGTGTGGSTYSKYDYPGTYSGADMDDCRTDITDYRDRWNVQHCEMGSLPDLDTGEEYVRKTIAGYLNDLLSLGVDGFRVDAAKHIAVDDLKDIKSRLTDPNAYMKLETIGAPGEAVQPSEYLGVGDPQEFTYAYDLKRVFSGEKLAYLKNFGEDWGYLPSDKASVFVTNHDTERNGRTLTYKDGATYTLAQVFSLAWPYGAPDVHSGYSFTDTAAGGPNGGQVNACYTDGWKCQHAWREVASMVAWRNTAHGEAVTDWWDNGNNQIAFGRGSKAYVAINHEGGSLTRTFQTSLPAGDYCDVQSGKGVTVNSAGQFTATLGANTALALHVGAKTCGGGSTDPEPAAGASFRVNATTSWGENIYVTGDNTRLGDWNPDNALKLDPAAYPVWKLDVSLPAGTSFEYKYLRKDANGKVTWESGANRTATVSSSGTVVLGDTWRD	MNFFTSPFSGIPLDQQVTNPNIIVGKHSYYSGYYHGHSFDDCVRYLHPERDDVDKLVIGSFCSIGSGAVFMMAGNQGHRSDWISTFPFFYQDNDNFADARDGFTRSGDTIIGHDVWIGTEAMIMPGVKIGHGAIIASRSVVTKDVAPYEVVGSNPAKHIKFRFSDVEIAMLLEMAWWNWPESWLKESMQSLCSSDIEGLYLNWQSKART	270.33	gnl|BL_ORD_ID|91|hsp_num:0	106			87	252	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000804.1|Acarviostatin_4 # 10118 # 11185 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.707	BGC0000804.1|Acarviostatin_4 	10118	11185	-	Loose	1020	31.187	tlrC	41.18	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGACGGCCTTGCGGCCGCTTCGCGCAACCGAGACCGGCACGCTGCGCCTCCACGACATCGCGGCCCAGGCGGCGGTGAGTGAGGCCACCGTCAGCCGGGTGCTCAACGGCAAGCCCGGCGTCGCCTCCGGTACCCGGCAGAAGGTCCTCGCCGCGCTCGACGTGCTCGGCTACGAGCGGCCGACACGGCTGCGCCGGCGCAGCGCCGGACTCATCGGGTTGGTCATCCCCGAGCTGACCAACCCGATCTTCCCCGCGTTCGCCCAGGTCATCGAGCAGGTCCTCGCGGGATACGGGTACACCCCGGTGTTGTGCACCCAGATGCCGGGCGGGGCGACCGAGGACGAACTGGTCGAACAGCTGGAGGAGCGCGGTGTCAACGGCATCGTGTTCCTTTCCGGGCTGCACGCGGATACCACGGCGGACGCGTTGCGCTACGCGCGGCTCGCCGAGCGGAAGGTGCCGTTCGTCCTCATCAACGGGTTCAACGAACACGTCAACGCGCCGTTCGTGTCCCCGGACGACCGCTCGGCGGCGCGAATGGCCGTGCGTCACCTCGTGGATCTCGGACACGAGCGCATCGGCCTGGCCGTCGGGCCGACCCGTTTCGTACCGTCCCGGCGCAAGGCGGAGGGCTTCGTGGCCGCGCTGCACTCCTTCCTCGGTACTCCCGGTGACGAGGCCGGAAGACTGATCCAGCGCACGCTGTTCAGTGTCGAGGGCGGCCATGCGGCCGCCGGCGCGCTGCTCGACCAGGGCTGCACCGGCATCGTCTGCGGCAGCGATCCGATGGCGCTCGGCGTCATCCGGGCGGTGCGCGAGCGAGGCCTCGACGTGCCGCGGGACGTGTCGGTGATCGGGTTCGACGACTCACCGCTGATCCCGTTCACCGATCCACCGCTGACCACGGTGCGCCAGCCCGTACAGGCCATGGCGACCGCGGCGGTGGGAGCGCTCCTGGAAGAGATCGGCGGTACGCCGGTCCAGCGGACGGAGTACGTGTTCCAGCCCGAGCTGGTGGTGCGGGGCTCTACGGCGCAGGTGGCGCGGAGCCAGGCGCACGCCTAG	MTALRPLRATETGTLRLHDIAAQAAVSEATVSRVLNGKPGVASGTRQKVLAALDVLGYERPTRLRRRSAGLIGLVIPELTNPIFPAFAQVIEQVLAGYGYTPVLCTQMPGGATEDELVEQLEERGVNGIVFLSGLHADTTADALRYARLAERKVPFVLINGFNEHVNAPFVSPDDRSAARMAVRHLVDLGHERIGLAVGPTRFVPSRRKAEGFVAALHSFLGTPGDEAGRLIQRTLFSVEGGHAAAGALLDQGCTGIVCGSDPMALGVIRAVRERGLDVPRDVSVIGFDDSPLIPFTDPPLTTVRQPVQAMATAAVGALLEEIGGTPVQRTEYVFQPELVVRGSTAQVARSQAHA	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	64.78	gnl|BL_ORD_ID|1841|hsp_num:0	1997			1470	1572	lincomycin; tylosin; mycinamicin
BGC0000804.1|Acarviostatin_5 # 11182 # 12843 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.712	BGC0000804.1|Acarviostatin_5 	11182	12843	-	Loose	400	30.8018	IND-6	26.44	3002262	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGAGCCAGTACCCGACCGACATGGCACCTGCCCGCGTCACCTCCACCCGCGAAGCCGCGGACTGGTGGCGAGACGCCGTCATCTACCAGGTCTACCCGCGCAGCTTCGCCGACAGCAACGGAGACGGCACCGGTGATCTCGAAGGCATCAGGCAGCGCCTCCCGTATCTGCGCGATCTTGGCGTGGACGCGGTCTGGCTGAGCCCGTTCTACGCCTCTCCGCAGGCGGACGGCGGCTACGACGTCGCCGACTACCGTGCCGTCGACCCCATGTTCGGCACTCTGCTGGACGCCGACGCGCTGATCCGCGACGCCCACGCCCTGGACCTGCGCATCATCGTCGACCTGGTGCCGAACCACTCCTCGGACCAGCACGAGTGGTTCAGGCGCGCGGTCGCCGAGGGGCCCGGGTCGCCGCTGCGGGAGCGCTACCACTTCCGCCCCGGCAAGGGAGAGAACGGGGAACTGCCCCCCAACGACTGGGAGTCCATCTTCGGTGGCCCCGCCTGGACCCGGCTGCCGGACGGCGAGTGGTACCTGCACCTCTTCGCGCCCGAGCAGCCCGACCTCAACTGGGAACACCCCGCCGTCGCCGACGAGTTCCGCTCGATCCTGCGGTTCTGGCTGGACATGGGCGTCGACGGCTTCCGCATCGATGTCGCCCACGGCATGGTCAAGGCCGAGGGCCTGCCCGACCTCGGCGGAAGCGACCAGCTCAAGCTGCTCGGCACCGACGTCATGCCGTTCTTCGACCAGGACGGTGTCCACGACATCTACCGCGCCTGGCGCCTCATCCTCAACGAGTACGACCGGGACAGGATCTTCGTCGCCGAGGCATGGACCCCGACCGTCGAGCGCACCGCCAACTACGTCCGTCCCGACGAACTGCACCAGGCCTTCAACTTCCAGTACCTGGGCGCACCCTGGGACGCCGCCGAACTCCGCGCGATCATCGACAGCTCCCTCGACGCCATGCGACCCGTCGGCGCCCCGGCGACCTGGGTGCTGTCCAACCACGACGTCACCCGGCACGCCACCCGGTACGCCAACCCGCCCGGCCTCGGCACGCAGATCCGCACTCCCGGTGACCGCGCGCTGGGCCTGCGTCGTGCCCGCGCCGCGACGCTGCTGATGCTCGCGCTGCCCGGCTCCGCCTACATCTACCAGGGCGAGGAACTCGGCCTGCCCGACGTCACCGACCTGCCCGACGAACTGCGCCAGGACCCGTCCTTCTTCCGGGCCCAGGGCCAGGACGGCTTCCGCGACGGCTGCCGGGTGCCGATCCCGTGGACCCGCGAGGGCTCCTCGTACGGCTTCGGCGCCGGCGGCAGCTGGCTGCCGCAGCCGGCGGGCTGGGGCGAGCTGAGCGTCGAGGCGCAGACCGGCGTCGCCGGCTCCACTCTCGAGCTGTACCGCACCGCCCTCGCCGTGCGCCGCGAGCAGCCGGGCCTCGGCGCCGGCACCGACGTGGTCTGGCACGACGACGCCCCGACCGGAACCCTGAGGTTCGACCGGCCCGGCTTCGCGTGCACCGTCAATACGACGGGGAGCGCGGTCCGCATCGCGGCACCCGGCCGCGTACTGCTCGCATCGAGCCCGGTCAGGGCAAGCGGCGACGAGTTCGAACTGCCCGCCGACACGGCCGTCTGGTGGGAGGTATGA	MSQYPTDMAPARVTSTREAADWWRDAVIYQVYPRSFADSNGDGTGDLEGIRQRLPYLRDLGVDAVWLSPFYASPQADGGYDVADYRAVDPMFGTLLDADALIRDAHALDLRIIVDLVPNHSSDQHEWFRRAVAEGPGSPLRERYHFRPGKGENGELPPNDWESIFGGPAWTRLPDGEWYLHLFAPEQPDLNWEHPAVADEFRSILRFWLDMGVDGFRIDVAHGMVKAEGLPDLGGSDQLKLLGTDVMPFFDQDGVHDIYRAWRLILNEYDRDRIFVAEAWTPTVERTANYVRPDELHQAFNFQYLGAPWDAAELRAIIDSSLDAMRPVGAPATWVLSNHDVTRHATRYANPPGLGTQIRTPGDRALGLRRARAATLLMLALPGSAYIYQGEELGLPDVTDLPDELRQDPSFFRAQGQDGFRDGCRVPIPWTREGSSYGFGAGGSWLPQPAGWGELSVEAQTGVAGSTLELYRTALAVRREQPGLGAGTDVVWHDDAPTGTLRFDRPGFACTVNTTGSAVRIAAPGRVLLASSPVRASGDEFELPADTAVWWEV	MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKTGVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPKTNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLVKSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK	231.38	gnl|BL_ORD_ID|538|hsp_num:0	590			198	450	
BGC0000804.1|Acarviostatin_7 # 13827 # 14834 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.663	BGC0000804.1|Acarviostatin_7 	13827	14834	-	Loose	200	25.0238	vanH gene in vanA cluster	53.85	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGACTGTCGCCGTGGAGCGCCCGGCCGCACCCAGTGGTGACGACCGCGGCCGGCGTCCGGGCCTCATCACCCGTCTCAAGAGCGGCTACCAGAAGCACTGGTACGCCTACGCGATGATCGCCCCGGTCGTTGTCGTGCTCGCCGTCATCGTGCTGTATCCGCTGGTCCGGGGCTTCTATCTGACGCTGACGGACGCCACGAGCCTCAACTCCGCCCGCACCATCGGCGTCAACCACATCGACGCCACCTACAAGTTCATCGGCCTCGACAACTACGCCGACATCCTGTGGGGACCGACGGCGTACGACCGCTTCTGGTCCCACTTCATCTGGACCATCGTCTGGACGGCCGCCTGCGTCGCGCTGCACTACGGTCTCGGTCTCGGCCTGGCCCTGCTGCTCAACCAGAAGGGGCTGCGCGGCCGCACCGCCTACCGGATGATGCTCATCCTGCCGTGGGCCGTGCCGACGTTCGTCACCGTCTTCGCCTGGCGCTTCATGCTCGCCGATGCCGGCGTCGTCAACACGACGCTCGACGCGCTCGGGATGCCCTCGCCGGCCTGGCTGGAGGATCCGCTCTTCCAGCAGATCGCCGCCATCATGGTCAACACCTGGTGCGGTGTGCCCTTCATGATGGTCTCGCTCCTCGGCGGCCTGCAGTCGATCGACTCGACGCTGTACGAAGCAGCGGAGATGGACGGCGCGAACGCCTGGCAGCAGTTCCGCAACGTGACCCTGCCCGGGCTCAGGTCGGTCAGCTCCACGGTCGTGCTGCTCGGCGTGATCTGGACGTTCAACCAGTTCGCGATCATCTTCCTGCTCTTCGGCAACACCGCGCCGGACGCGCAGATCCTGGTCACCTGGGCCTACTACCTCGGCTTCGGACAGACTCCGCGCGACTACGCCCAGTCCGCGACGTACGGCGTCCTGCTGCTGTCCCTCCTCATCGTGTTCACCTCCGTCTACCGCCGCTGGCTGAACCGCAACGACGTGCAAGCCGCCATCTGA	MTVAVERPAAPSGDDRGRRPGLITRLKSGYQKHWYAYAMIAPVVVVLAVIVLYPLVRGFYLTLTDATSLNSARTIGVNHIDATYKFIGLDNYADILWGPTAYDRFWSHFIWTIVWTAACVALHYGLGLGLALLLNQKGLRGRTAYRMMLILPWAVPTFVTVFAWRFMLADAGVVNTTLDALGMPSPAWLEDPLFQQIAAIMVNTWCGVPFMMVSLLGGLQSIDSTLYEAAEMDGANAWQQFRNVTLPGLRSVSSTVVLLGVIWTFNQFAIIFLLFGNTAPDAQILVTWAYYLGFGQTPRDYAQSATYGVLLLSLLIVFTSVYRRWLNRNDVQAAI	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	104.04	gnl|BL_ORD_ID|4669|hsp_num:0	178			225	303	vancomycin; teicoplanin
BGC0000804.1|Acarviostatin_8 # 14948 # 16222 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.667	BGC0000804.1|Acarviostatin_8 	14948	16222	-	Loose	600	33.113	LUS-1	24.27	3006942	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	LUS beta-lactamase	ATGCGGCGTGGCATAGTGACCACCGCGGTGGTGGCGTCCCTCGCACTCGCGGCGACGGCCTGCGGCGGAAGCGATGACGGGGGCAAGGCCTCCGGCCCCGTGACCATCACATGGTGGGACACGTCGAACGCCACCAACGAGGCGCCCACGTACAAGGCCCTGATCAAGGACTTCGAGAAGGCCAACCCGGACGTCAAGGTCAAATACGTCAACGTCCCCTTCGACCAGGCCCAGAACAAGTTCGACACGGCGGCCGGCGCCAGCGGCGCACCCGACGTGATTCGTGCCGAGGTCGGCTGGACCCCGGCCTTCGCGAAGAAGAGCTACCTGCTGCCGCTCGACGGCACCGTGGCGCTCGACGAGCAGGACAAGTTCCAGCCGAACCTGATGAAGCAGGCCCAGTACGAGGGCAAGACGTACGGTGTTCCGCTGCTCACCGACACGCTCGCGCTCGTGTACAACAAGGAGCTCTTCGAGAAGGCGGGCATCAGCGAGGCGCCCAAGACCTGGGACGAGCTGAAGAAGGCCGCCGCCACCATCAAGGACAAGACCGGCGTCGACGGGTTCTTCGGTTCCGAGAAGGGCTACTACCTCGAGCCGTTCCTCCTGGGCGAGGGCACCGACACGGTCGACGCCGAGGCCAAGAAGATCACGGTGAACTCCGCCAAGGGACAGAAGGCGGCCGAGACCTGGCTGAGCCTGTTCAACGGCAAGGGCCTGCACAAGGCGGACGTCACGGCCGACTCGTACGCGCACCGCCAGGACGCGTTCGTCAACGGCAAGGTCGCCATGACCATCGAGGGTCCCTGGGAGATCACGAACTTCTACAAGGGCACCGCGTTCAAGGACAAGAACAACCTCGGTGTCGCCACCGTCCCGGCCGGTTCCACCGGCAAGGCGGCCGCTCCGACGGGCGGCCACAACCTGTCCGTCTACGCCGGATCCGACAAGGCCCACCAGGACGCGGCCCTGCAGTTCGTCAAGTGGATGACCTCCGCGAAGGCGCAGGAGCAGATCGCCCTGAAGAACTCGACGCTGCCCACGCGCTCGGACGCGTACACCGAGAAGGTGACCGCCGACCCCGGCCTCGCCGGATTCCAGAAGGTGCTCTCCGCCGCCCAGCCGCGGCCCGAGCTGCCCGAGTACAGCTCGCTGTGGGGGCCGCTCGACCAGGAGCTGCCCAAGGCGGCCAGTGGCAAGGAGAGCCTCGACGCAGTCCTGTCCTCCGTCGAGGTCCAGTACGGCAAGCTCCTGCCCGACGGCTTCAGCAAGTGA	MRRGIVTTAVVASLALAATACGGSDDGGKASGPVTITWWDTSNATNEAPTYKALIKDFEKANPDVKVKYVNVPFDQAQNKFDTAAGASGAPDVIRAEVGWTPAFAKKSYLLPLDGTVALDEQDKFQPNLMKQAQYEGKTYGVPLLTDTLALVYNKELFEKAGISEAPKTWDELKKAAATIKDKTGVDGFFGSEKGYYLEPFLLGEGTDTVDAEAKKITVNSAKGQKAAETWLSLFNGKGLHKADVTADSYAHRQDAFVNGKVAMTIEGPWEITNFYKGTAFKDKNNLGVATVPAGSTGKAAAPTGGHNLSVYAGSDKAHQDAALQFVKWMTSAKAQEQIALKNSTLPTRSDAYTEKVTADPGLAGFQKVLSAAQPRPELPEYSSLWGPLDQELPKAASGKESLDAVLSSVEVQYGKLLPDGFSK	MKGFFRIKSVVCGVFLLMISVNAFAQKSELREKLQRIVNAHSATIGFSLTDLRNGDTLTVNGTKHLPMQSVYKFHLALAVLDQVDQGKLKLDQKIMVKKSDLLPDTWSPLRDKYPNGEVEIPLSEILSFTVSQSDNNGCDILFRLIGGPAKVNRYIHHLGIKDVAITATEEQMHQNDQIQFTNWTTPQAATELLGLFYAKKILSPASHEFLCKVMTETSTGADKIKGLLPAGTLAAHKTGSSGANKSGLTAASNDIGIVTLPDGKHFAVAAFVSMTKEDEKATDLIIAELTKASWDYLTTGKP	139.93	gnl|BL_ORD_ID|3683|hsp_num:0	4753			294	588	
BGC0000804.1|Acarviostatin_9 # 16248 # 16673 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.620	BGC0000804.1|Acarviostatin_9 	16248	16673	+	Loose	500	23.8682	mecC-type BlaZ	38.46	3005097	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BlaZ beta-lactamase	GTGAGTGGGCGAGGAACGGTCCCGTCCGTACCTCTGGCCGACTTGCCGACTGAGCCGTCGCGGCCACCGGGCGACGTGAACGTAACAGTGGAGAAAGACTGGCGAAAGACGTTGCGCGAATTTTCTGCAAGAACTGCCCATCGTTACTTCTTCGTATCCCATCGGTTGCCGACGGAATACTTGACGTGGCGCGCATCCTTGAGACGCAGTGGCGCGAATCACCGCAAAATAGATGATGATGGGCCCGGTCCGCCCAACAGCTTCCCTCTTCGTGCCGCACGGGGCTGCAAGGTCTTCCGCAAGGACACCGGCTACACCATCACGGTGGCCGTCCGGTGCTGGTGGGCTTTCCCCCTGGTAACGGGTAGAGTCCCTGTCCATGACCGCGCGGCTCTCCGACATCGCAGCCCAGGCGGGAGTCAGTGA	MSGRGTVPSVPLADLPTEPSRPPGDVNVTVEKDWRKTLREFSARTAHRYFFVSHRLPTEYLTWRASLRRSGANHRKIDDDGPGPPNSFPLRAARGCKVFRKDTGYTITVAVRCWWAFPLVTGRVPVHDRAALRHRSPGGSQ	MKKLIILVVLALILSACNSKNSTNNDIEKIEKKYGANVGMYALNTQNGKELSFNENKRFAYASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITLKKLIEATMLFSDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPDLNFYSPKDKRDTSTPLAYGKTLKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVAFVYPDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLKNINE	49.82	gnl|BL_ORD_ID|2812|hsp_num:0	3829			396	513	penicillin
BGC0000804.1|Acarviostatin_10 # 16627 # 17655 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000804.1|Acarviostatin_10 	16627	17655	+	Loose	570	25.7942	OXA-151	46.43	3001456	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCGCGCGGCTCTCCGACATCGCAGCCCAGGCGGGAGTCAGTGAAGCCACCGTCAGCCGCGTGCTCAACGGCAAGCCAGGAGTGGCCACCGGCACCCGCGAGTCCGTCATGGCGGCACTCGACGTACTCGGGTACGAGCGACCGCCGCGGTTGCGCACCCGAAGCGCCGGCCTGGTGGGCCTGATCACCCCCGAGCTGGACAATCCCATTTTCCCCGCGCTCGCCCAGGTCATCGGCCAGGCGCTCACGCGCCAGGGATACACGCCGGTCCTCGCCACCCAGACTCCGGGCGGCTCGACCGAGGACGAACTCACCGAGATGCTGGTGGAACGCAGCGTTTCCGGCATCATCTATGTCTCAGGGCTGCACGCCGACACCACCGCCGACACCCAGAGGTACGACCAACTCCGCGGTCAGGGCATACCGTTCGTGCTCGTCAACGGGTTCTCGGCGCACATCGAGGCCCCTTTCGTATCCACCGACGACCATGCCGCGACGCGCCTGGCCGTGCAGCATCTCGCCTCGCTCGGCCACACGCGGATCGGCCTCGCCGTCGGCCCGCGCCGGTTCGTCCCGGTGCAACGCAAGATCGCGGGCTTCCTGGCCGGGATGTCCGGGTATCTGGGCCTGAGTGAGGAACAGGGCGAGGAGCTTGTGCAGCACTCCCTCTTCACCATGGAGGGCGGCCAGGCAGCGGGTACCGCGCTCCTTGCGCAAGGTTGCACCGCCATCGTCTGCGCCAGCGACATGATGGCGCTGGGCGCCATCCGAGCCGCCCGCCAAGCCGGCTGCCGGGTCCCCCAGGACGTCTCCGTGGTCGGCTTCGACGATTCTCCGCTGATCGCTTTCACCGACCCGCCCCTCACCACCATCCGTCAGCCGGTGCACGCCATGGGCCAGGCCGCCGTCCGCGCGGTTCTCGAGGAGATCGGCGGAACCCCCGCGCCCCACACCGAGTTCATGTTCATGCCCGAGCTCGTGGTACGCGGCTCGACCACCGCGGCGCCCATCACCCGCCCCCGCTGA	MTARLSDIAAQAGVSEATVSRVLNGKPGVATGTRESVMAALDVLGYERPPRLRTRSAGLVGLITPELDNPIFPALAQVIGQALTRQGYTPVLATQTPGGSTEDELTEMLVERSVSGIIYVSGLHADTTADTQRYDQLRGQGIPFVLVNGFSAHIEAPFVSTDDHAATRLAVQHLASLGHTRIGLAVGPRRFVPVQRKIAGFLAGMSGYLGLSEEQGEELVQHSLFTMEGGQAAGTALLAQGCTAIVCASDMMALGAIRAARQAGCRVPQDVSVVGFDDSPLIAFTDPPLTTIRQPVHAMGQAAVRAVLEEIGGTPAPHTEFMFMPELVVRGSTTAAPITRPR	MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFTAEGVKGTIVVLDARTQTYQAYDAARAEKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKPRRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRRYAQAKLNEVGYGNRTIGGAPDAYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDIGWWVGWIERDGNIASVAINIDMLSEADAPKRARIVKSVLKDLKLI	120.00	gnl|BL_ORD_ID|2521|hsp_num:0	3415			609	693	cloxacillin; oxacillin; cefalotin
BGC0000804.1|Acarviostatin_11 # 17674 # 18651 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0000804.1|Acarviostatin_11 	17674	18651	-	Loose	1200	37.7354	arnA	23.14	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCCGACGCATCCTCGTCACCGGCGGAGCCGGCTTCATCGGCTCCGCATACGTTCGTGCCCTGCTGGGGCCGGCCGGGCCACCGGGCATCGAGGTGACCGTGCTCGATGCCCTCACGTACGCCGGCAGCCTCACCCGCCTGGAATCCGTCACCGGCGACCCTCGGCTGTCCTTCGTACACGGCGACGTGCTGGATGCCCGTTCGGTGGAGCGGCTCGCCGCTCAACACGAGGACATCGTGCACTTCGCGGCCGAGTCCCACGTCGACCGGTCGATCGCCTCCGGCGCGGCCTTCACCCGCACCAACGTCATGGGCACCCAGACTCTCCTCGACGCCGTGCTCCGACAGGGCACCCGCACCTTCGTCCAGGTCTCCACCGACGAGGTGTACGGCGACCTGCCGGCCGGCGCCGCCACGGAGGACTCCCCGCTGAGCCCCAACTCGCCCTACGCGGCGTCCAAGGCCGCCGCCGACCACGTGGCACTGGCTCATCACCGCACGCACGGCCTGGACGTCCGGGTGACACGCTGTTCGAACAACTTCGGTGCCTACCAGCATCCCGAGAAGCTGATCCCGCGCTTTGTGGCGGCGCTGTTCAGCGGCGGTAAGGTCCCGGTCTACGGGGACGGGCTGCAGGTGCGGGACTGGCTGTCGGTCGACGACCACGTGCGGGGCATCGAACTCGTCCGCACGGCGGGCCGCGCCGGTCGCGTCTACAACATCGGTGGCGGTACCTCACTGACCAACCTCGACCTGACCCACCGGCTGCTCGAACTGTGTGGTGCCGGCCCCGACCGCATTGAGCACGTGGAGGACCGCAAGGGGCACGACCGCCGCTACGCGGTGGACCACACGCGTATCACCCAGGAACTCGGCTACCGACCGTCCGGCGACTTCGAGCGGGCGCTCACGCGGACCGTGGCCTGGTACCGCGAGCACCCGCACTGGTGGCGACCGCTGTACGAGGCAGCCTGA	MTRRILVTGGAGFIGSAYVRALLGPAGPPGIEVTVLDALTYAGSLTRLESVTGDPRLSFVHGDVLDARSVERLAAQHEDIVHFAAESHVDRSIASGAAFTRTNVMGTQTLLDAVLRQGTRTFVQVSTDEVYGDLPAGAATEDSPLSPNSPYAASKAAADHVALAHHRTHGLDVRVTRCSNNFGAYQHPEKLIPRFVAALFSGGKVPVYGDGLQVRDWLSVDDHVRGIELVRTAGRAGRVYNIGGGTSLTNLDLTHRLLELCGAGPDRIEHVEDRKGHDRRYAVDHTRITQELGYRPSGDFERALTRTVAWYREHPHWWRPLYEAA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.09	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1950	polymyxin B
BGC0000804.1|Acarviostatin_12 # 18729 # 19802 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.708	BGC0000804.1|Acarviostatin_12 	18729	19802	-	Loose	400	26.9498	vatE	50.0	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGAAGGCCCTGCTCCTGGCGGGCGGAACGGGTAGCAGACTGCGTCCCTTCACCCACACCGGTGCCAAGCAGCTGATGCCGATAGCCAACCGGCCGGTTCTCTCCTACGCGCTCGACGCGCTGGCGGCCGCCGGAATCGCCGAGACGGGCATCGTCGTCGGCTCCCACGAGAGGGAGATCCGCCGGGTGGTCGGAGACGGCTCGGCCTTCGGCCTGCGGGTCACCTACCTGCGCCAGCACCGCCCCCTGGGCCTCGCCCATGCGGTGCGGATCGCCCGCGACTTCCTGGGTGACGACGACTTCCTCCTCTACCTCGGTGACAACTACCTGCCCGAAGGGATCACCGGTTTCCTGCGGCGAGCCCGGACCGAACGGGCGGCGGCCCGGCTGCTGTTGACGCGGGTCGCCGACCCGACCGCCTTCGGTGTGGCCGAAGTCGAGGGAGGTGACGAAGGCAGGGTGCTGCGGCTGGAGGAGAAGCCCGAACACCCGCGCAGCGATCTGGCCCTCGTGGGCGTCTACGCCTTCACCGCCGCCGTGCACGAGGCGGTCCGGTCCATCTCCCCCTCCGCCCGCGGGGAACTGGAGATCACCCATGCCGTCCAGTGGATGATCGACCAGGGGCTCCCGGTGCGCGCGGAGACCACGGCGGCGCCCTGGCGGGACACCGGCAGCGTCGACGACATGCTGGAGGTCAACCGGCACGTCCTGGACACCGTGACCGGAGGCATCGAGGGCAAGGTCGACGCCGAGAGCACGGTACGCGGACGGGTCCTCGTCGCCGAGGGAGCCGTGGTGCGGGGCTCACGGATCACAGGTCCGGCGATCATCGGCGCCGGAACAGTGGTCACCGACTCCATGATCGGGCCCTATACCGCGGTCGGTGAGGACTGCCGCATCGAGGACAGCGCGATCGCCCACTCGGTGCTGCTGCCCGGGGCACGGATCGCGGGCGCCCCACGCATCGAGGACTCCCTCATAGGCCGCGGCGCGGTCGTCGTGGCGTCCCCGCGGCTGTCGCGCTCGCACAGGCTCGTCATCGGGGACGACAGCAGGGTCCACCTCACTTCGTGA	MKALLLAGGTGSRLRPFTHTGAKQLMPIANRPVLSYALDALAAAGIAETGIVVGSHEREIRRVVGDGSAFGLRVTYLRQHRPLGLAHAVRIARDFLGDDDFLLYLGDNYLPEGITGFLRRARTERAAARLLLTRVADPTAFGVAEVEGGDEGRVLRLEEKPEHPRSDLALVGVYAFTAAVHEAVRSISPSARGELEITHAVQWMIDQGLPVRAETTAAPWRDTGSVDDMLEVNRHVLDTVTGGIEGKVDAESTVRGRVLVAEGAVVRGSRITGPAIIGAGTVVTDSMIGPYTAVGEDCRIEDSAIAHSVLLPGARIAGAPRIEDSLIGRGAVVVASPRLSRSHRLVIGDDSRVHLTS	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	166.82	gnl|BL_ORD_ID|1398|hsp_num:0	1519			384	477	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000804.1|Acarviostatin_13 # 20035 # 21333 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.717	BGC0000804.1|Acarviostatin_13 	20035	21333	+	Loose	750	25.7942	tet(39)	30.88	3000566	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGGCACCAGCACCACCAGCTCGACCAGTTGGAGCGGGAGGAGTTGCGCCTGGCACCCGGAGCCTCCGAGGAGGCGACCGCGGGACGGCGGGTCTTCGCCGAAGGACGCGGCCCCGTACTGACCGACCTGGACGGCAACCAGTACCTCGACTTCGCCGCCGGCACCCTCACTCAGTCCCTCGGGCACACCCATCCCGAGGTGGTCGAGGCGCTCACCGCCCAGGCACACCGGCTGTGGAACGTGCACGACACCGCCACGCCCGACCGGGCGCGACTCCTCGACACCCTGGCCCGGCTGCTTCCCGAACACCTCGACACATACGCGCTGTTCTCCACCGGTGCCGAGGTGGTCGAGGCCGCCCTGCGCGTCGTACAGGCGACCGCGCCGCCGGGACGCAACCGGATCGGCGCGCTGCGGCACGGCTTCCACGGCAAAACGCTGGGGGCACGGATGCTCGTGCACTGGGACATCGGTCACCAGTCGTTCGCGGGCAACAGCGTGCTCGGCTACGCGCCCTACTGCTACCGGTGTCCGCTGGGCCTGGAGTACCCGTCCTGCGGTGTGCGCTGCGCGTCGCTGGTACGCCGGCACATCACCGACAAGCCCAGCACGTCTGCCCTGGTCTTCGAGCCGGTGCTCGGCGCGGCCGGCGTCATCGTGCCGCCGGCCGGCTACTGGGACCAGATCGCCGACGCCTGCCGGGCAAGCGGTGTGCTGCTCGTCGCCGACGAGGTGCTCACCGGCGGCGGTCGCACCGGCGCCTTCCTGGCCAGTGACCGCGTCGGGGTGGAGCCGGATCTGGTGGCCATGTCGAAGGGCATGGCGAACGGCTTCCCCTTCGCCGTGCTCGCGGGCCGCCACGACCTGCTGCACGATCCCGCCGCGGCGACACCGGGTGCGTACGCCTCCACCTATGCGAGCAACCCGCTCGGGATAGCGGCCGCACGCGCGACCCTGGAGGTCATCGAGCGGGACCGCCTGATCGAACAGGTGGACCGTCTCGGCGAGGTGCTCGGTGACCGGCTCCGAGCACTGCACGACCGGTTCGAGAACCTCGGGGAGGTGCGCGGGCTCGGGCTGCTGTGGGGCCTGGAGTTCGTGACCGACCGGGCCAGCCGCACCCCCTCCCCCGCACTCGCCCGCTCCGTGTACACGACCGCGCTGGATCTGGGGCTGCGGGTCGCGCTCGGCGGGCACGTGCTGCGCATCGCACCACCCTTCACGATCGACGAGGCGCTGGTGGACGAGGGTGTCGGACTGCTCGCGAAGGCGATCGAACAGGCGGTGGACGCGTGA	MRHQHHQLDQLEREELRLAPGASEEATAGRRVFAEGRGPVLTDLDGNQYLDFAAGTLTQSLGHTHPEVVEALTAQAHRLWNVHDTATPDRARLLDTLARLLPEHLDTYALFSTGAEVVEAALRVVQATAPPGRNRIGALRHGFHGKTLGARMLVHWDIGHQSFAGNSVLGYAPYCYRCPLGLEYPSCGVRCASLVRRHITDKPSTSALVFEPVLGAAGVIVPPAGYWDQIADACRASGVLLVADEVLTGGGRTGAFLASDRVGVEPDLVAMSKGMANGFPFAVLAGRHDLLHDPAAATPGAYASTYASNPLGIAAARATLEVIERDRLIEQVDRLGEVLGDRLRALHDRFENLGEVRGLGLLWGLEFVTDRASRTPSPALARSVYTTALDLGLRVALGGHVLRIAPPFTIDEALVDEGVGLLAKAIEQAVDA	MKKSLSVILITIFLDAVGIGLIMPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPILGALSDRFGRRPVLIISIAGATADYLLMAAAPSLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGVLGEWNLHAPFFAAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFLIITLVSQVPATLWVIYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTLLCGIACDAIGLLLLSIAVEEWVPFALLPLFALGGVAVPALQAMMSRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMTQASAPGMVWALAAILYVITLPLLLKYRLNKYSGVP	109.37	gnl|BL_ORD_ID|1037|hsp_num:0	1092			984	1173	tetracycline
BGC0000804.1|Acarviostatin_14 # 21330 # 22355 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.703	BGC0000804.1|Acarviostatin_14 	21330	22355	+	Loose	650	124.79	tetA(58)	30.72	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGATCGTCGCACACGAACTGGTCAAGGAGTTCAAGATCCCGGAGCGGCGGCCGGGCCTGGCGGGCTCGCTCGCCACCCTCTTCACCCGCAGACACCGGGTGGTACGCGCCGTGGACGGCGTCTCCTTCGAGATCCCGGCCGGCTCACGCACCGCCTACATCGGCGCGAACGGCGCCGGCAAGTCCACCACCATCAAGATGCTCACCGGCATCACGACCCCCACGGCGGGGTACTGCCGGGTGCGCGGCATAGAGCCGTATCGCCACCGGCAGCGCAACGCCCGGTCCATCGGGGTCGTCTTCGGGCAGCGCAGCCAGCTGTGGTGGGACCTGTCCGTGCCGGACTCGTTCCGCATCCTGCGGCGGATCTACGACATCCCGGACCCCGTCTACCGGCGCAACCTGGCCCTGTACCGCGACCTCCTCGACATCGATGCGCTCGGGACCACACCGGTGCGGCAGCTGAGCCTCGGACAGCGCATGCGCGCGGAGATCGCGGCGAGCCTGCTGCACGACCCGGCGGTGGTGTTCTGGGACGAACCCACGATCGGGCTCGACATGGTGCTCAAGGAGGCCGTGCGCGAACTGGTCAACCACGCTCACCGCGAGCTGGGCACCACCGTCGTACTGACCAGTCACGACATCGCCGACATCGCGGCCATCTGCGACAGCGCCCTGGTGGTGGACCGGGGCCGGGTGGTGCATCAGGGCAGCATCCAGGACCTGTTGCGCTCGGCCGACCGGCGTGCCGTCCTCTTCGACCACCGCGACCCGATCGCGCCGGACACTGCCTGCGCGATCGTGGAGCAGGGACTGCCCGGGGTGCGGGCCACGGTGGTCGACGGCGGCCGCGTCCACGTCGACTACCCCGCGACGGAGTTCACCTCCCGCCGCGTACTCGCCTTCCTCCTGGAACGCTTCGACCTGGCCGACTGCTACGCGCCCGAGCCCGACCTCGAGGACGTGCTGCGCCAGATCTACGGGCAGCGACGTGACGCGGCCCTCCGTGAGGTGGACGCCGCGTGA	MIVAHELVKEFKIPERRPGLAGSLATLFTRRHRVVRAVDGVSFEIPAGSRTAYIGANGAGKSTTIKMLTGITTPTAGYCRVRGIEPYRHRQRNARSIGVVFGQRSQLWWDLSVPDSFRILRRIYDIPDPVYRRNLALYRDLLDIDALGTTPVRQLSLGQRMRAEIAASLLHDPAVVFWDEPTIGLDMVLKEAVRELVNHAHRELGTTVVLTSHDIADIAAICDSALVVDRGRVVHQGSIQDLLRSADRRAVLFDHRDPIAPDTACAIVEQGLPGVRATVVDGGRVHVDYPATEFTSRRVLAFLLERFDLADCYAPEPDLEDVLRQIYGQRRDAALREVDAA	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	99.42	gnl|BL_ORD_ID|2243|hsp_num:0	2517			90	987	tetracycline
BGC0000804.1|Acarviostatin_16 # 23173 # 23979 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.690	BGC0000804.1|Acarviostatin_16 	23173	23979	+	Loose	1000	26.9498	HelR	32.65	3007208	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	helicase-like RNA polymerase protection protein	ATGAGCGCACGGAGCACGGCGGCGCGGTACGCGCGTCTGTCCTGGTTTCTGGGCGGTGTCGGTCTGCACCGGCTCACCGCCTACCGGTTGGACTTCCTGCTCGGTGCCGGCGCGTTCCTGGTCCGGGTCGGGGTGCAGACGGCCGTGGTCGGCCTGGTGTTCCGGCAGGTGCCGGTGGTGGGCGGCTGGTCGTACCACGAGGTGGTGTTCCTGCTGGGCTTCTCCCTGCTGCCGCGGGGCCTCGACCATCTCTTCACCGACCAGCTGTGGGAGCTGAGCCGCAAGCTGGTGCAGCGCGGTGAGTTCTACCGGCACCTGGTGCGGCCGGTCAGCCCGCTGTTCTCACTGCTTTCCGAGCGGTTCCTGCACCCGGACGGGTTCGGCGAACTGATCGTCGGCGCGGCCCTCGTGGGCTGGTCCGGATCTCATCTCGACCTGGACCTGACCGCGGCCCAGTGGGCGCTGGCCCCTCTGTTGGTCCTGTGCGGAGCGCTGATCCACTCGGCGGTGAAGCTCCTGTTCGCCTCGCTGTCCTTCTGGACGGTCACCAGCCTGCCCGCCATGTACGCGGCCAACCAGGTCTCCGAGTTCACCTCCTACCCGCTGGACATCTACCACCCGACCCTGCGGGCCCTGCTGACCTGGGTGCTGCCCTTCGCCTTCACCTCGTACGTGCCCTGCACCTATCTGCTGACCGGCGACACCGGGCTGGTGGTGTGGCTGCCGGTGGTGACGGCGGGAGCGGTCGCGCTCGCACTCGCGGTGTGGCGGCGAGGTCTGACCATCCACGACACGACCGGGAGTTGA	MSARSTAARYARLSWFLGGVGLHRLTAYRLDFLLGAGAFLVRVGVQTAVVGLVFRQVPVVGGWSYHEVVFLLGFSLLPRGLDHLFTDQLWELSRKLVQRGEFYRHLVRPVSPLFSLLSERFLHPDGFGELIVGAALVGWSGSHLDLDLTAAQWALAPLLVLCGALIHSAVKLLFASLSFWTVTSLPAMYAANQVSEFTSYPLDIYHPTLRALLTWVLPFAFTSYVPCTYLLTGDTGLVVWLPVVTAGAVALALAVWRRGLTIHDTTGS	MRVLSSVDQLDGTSAFDLPDRLSAKTDPALIAADERHFSAIAKSLAETITELSDRLDATRKAPGGVGREAMDRDAEIHRLTGRLRTLRRFGLDLCLGRIVTADDAEPVYVGRLGLTDSTGRRLLVDWRSPAAEPFFAATHADPMGLTSRRRYRWTGGRVSDYWDEVFTADGLEEHAALDDQSAFIASLGSSRSPQMRDVLATIQADQDAIIRAGSRGTLVVDGGPGTGKTVVALHRSAHLLYADPRLGHRRGGVLFVGPHQPYLAYVADVLPSLGEEGVRTCTVRDLVAEGAGAAVERDAEVARLKSSADMVRAIEAAVRFYEEPPTQRMTVSTDWADVRLTADDWAEAFDAPEAGTPHNEAREQIWEELGSILLGKLGDEVPEEEFRRALRQDEELAGALHGAWPLLEAADLVGDLWSVPAYLRKCAPWLDREDVAKLQRADAQAWTVSDLPLLDAARQRLGDPEAARRRRRQQATVAAERARMADVIADVLAADDDGEGAVTMLRGQDLKDTLVDEAALTGVEPDLLAGPFAHIVVDEAQELSDAEWQMLLLRCPSRSFTIVGDRAQARHGFTESWEERLARVGLDRITVASLSINYRTPEEVMAEAEPAIRAALPDANVPTSVRSSGVPVLRGPVEELDTIVDEWLAANADGTACVIGAPRFRPGPRVRSLTPSLSKGLEFDLVVLVDPEDFGGGIEGAVDRYVAMTRATKQLVILTSS	37.12	gnl|BL_ORD_ID|4837|hsp_num:0	5819			1233	1380	rifampin; rifaximin; rifabutin
BGC0000804.1|Acarviostatin_17 # 23986 # 25449 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.734	BGC0000804.1|Acarviostatin_17 	23986	25449	+	Loose	750	27.7202	MexE	35.71	3000803	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACGGTGCCGAAGCGGATGCGGGCCTGGACGGGCTGCTGCGCGCCGCCCCCTGGATGCCCGAGGACGCGCGCGCCGCCGAGCGTTTCGAGCGAATCGATCACGCGGTACTCGGCGGGGCGGCGTTGCTCCTGATCGTGGCGGCCGTCGGCGGTCCCGCGTCAGGTCGCCGGTTCTTCGTACCGGTGCGCGGAACCGACGGTGGCGGCTTCGAAGCGGCGCACGGCAGCGAGGCATTCGACGTCGCCGCGGTGACTCGTACGCTGACCGGCGGAAAGCTGCCTACAGCGCGAGGCGGGTCCGTCGAGTTCCGGGGACCCGGGCGCGGTCCGATCGGGGTGCGGCGCCTGCCGTTCGAGCAGGGCTGGTCCTCCAACGCGCTGTCGCTGGTGGACGTGTCGGGCACGGCCTGCATCCACAAGACGTACCGCCGTCTGGACGAGACCATCCACGAGCCGGAGCTGCTGCGCCGCATGAACGGCACCGGCCGCACCCCACAGTGGGTGGGCGACTACACGTACGTGGCGCCGGACGGCACGTCCCGCAGTCCGCTCGGCGTGATCTACCAGTACGTCCAGGGCGAGGGCATCGACGTCCCGCTGCGCGGGAACCTCCGCTCGATGTGGCCGCGGCTCTCGGGCACCACGTCCGTCGAGGAGGTCGTCCGCTCCCACCTGGGGCCGCTGGAAGAACGGTTGCGCCGGGCCTGCGAGTTCCTGGGCGACTTCCACCGGGACCTGGCACACCGGCTGGGCGGCGCCGCCGAGTATCCCGTGCGCGAGGCCCTGGACGACGCGGTGGACCGCGCCGACCGTCTCGCCCGGCACGGCACCGGACTGGCACTGCCGAAGTCCGCGCACGAGGCCGCCTTCGACGCCCTGCACACAGAACTCGCCGCGCTCGCGGCGGAGTTCGACGACGGGAACATTCCCGCATCCGGACCCTGCCACGGTGACCTGCACCTCTCCCATCTGCTGTGCGCGGCCGACGGCGACAGGGGGGCCGGAGCCGGCTGGCGCATGACGGTGCTCGACCTGTCCACGCCGGCGCTCGGCCCCGACGACCCGGACTGGCCCCGGCAGTCGCCCCTGCAGGACCTGGTCGCTCTCGAGCGCGCTCTGGAGTACTTCGCGGCCGACGAGGCGGCGTTCGAGGCCGCGCGGCGACTCGGCGTGGACTCGCTGGAGACGATGCTCGGCTCTCTGGACGGCGCTCCGCACTGGCCCGAAGCCCGGCGGGCGGTGCTGCGGCAGGTGTTCGCGGCGGCCGACGCGTGGCGGCGGCACGTGACGCGGCTGCTGCTCGGTTCCGCCTCCGACCACCCGCTGCGCCGCCTGCTGTACGTCCGCAGGCTGCTGCACGAGCTCACCTACAACCAGGCCCATGCCCGCCCCTACCACGCGGCGATCGACCTGCGTCACGCTCGCGCGCTCGCGCCGGCCGCCGCGTTCGCGAGGAAGTGA	MHGAEADAGLDGLLRAAPWMPEDARAAERFERIDHAVLGGAALLLIVAAVGGPASGRRFFVPVRGTDGGGFEAAHGSEAFDVAAVTRTLTGGKLPTARGGSVEFRGPGRGPIGVRRLPFEQGWSSNALSLVDVSGTACIHKTYRRLDETIHEPELLRRMNGTGRTPQWVGDYTYVAPDGTSRSPLGVIYQYVQGEGIDVPLRGNLRSMWPRLSGTTSVEEVVRSHLGPLEERLRRACEFLGDFHRDLAHRLGGAAEYPVREALDDAVDRADRLARHGTGLALPKSAHEAAFDALHTELAALAAEFDDGNIPASGPCHGDLHLSHLLCAADGDRGAGAGWRMTVLDLSTPALGPDDPDWPRQSPLQDLVALERALEYFAADEAAFEAARRLGVDSLETMLGSLDGAPHWPEARRAVLRQVFAAADAWRRHVTRLLLGSASDHPLRRLLYVRRLLHELTYNQAHARPYHAAIDLRHARALAPAAAFARK	MEQSSHFSWRYPLALAAVLVLSACGKAPETTQGMAAPKVSVAEVIEQPLNEWDEFTGRLEAPESVELRPRVSGYIDRVAFHEGALVKKGDLLFQIDPRPFEAEVKRLEAQLQQARAAQARSVNEAQRGERLRASNAISAELADARTTAAQEAKAAVAATQAQLDAARLNLSFTRITAPIDGRVSRAEVTAGNLVNSGETLLTTLVSTDKVYAYFDADERVFLKYVELARQAGRDTRSESPVYLGLSSEDGNPHLGRLDFLDNQVNPRTGTIRGRAVFDNAKGEFTPGLYVRLKLVGSKTYAATLIKDEAVGTDLGKKFVLVLDGDNKTVYRTVEMGPKLEGLRIVRSGLSKGDRIVVNGLQRVRPGMQVDPQKVEMASADTLATLARLRQSVGDSEPPKVAASKDNATRNEPRG	117.63	gnl|BL_ORD_ID|1038|hsp_num:0	1067			591	759	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000804.1|Acarviostatin_18 # 25457 # 27544 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.705	BGC0000804.1|Acarviostatin_18 	25457	27544	+	Loose	500	26.5646	CTX-M-144	24.05	3002002	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGGAACCGCGTATGCACATCATCGAGACGTACTTCGAATGCTGCGGCTTCGACCACACCTTCATCCAGGGCGGCACGTCCGTCTATCTGTGGAATCTGTCGAAGAAGTTCGCCCAGAGCGGCCACCGGGTCTCCATCGTGACCCCGGCCCACGGGCGCCTCGACGACCTGCGCACCCGTTACGAGGTCGAGGACCTGCCGTACGAGGACGCGTACACGCTGCCCGTCCCGCTCGACCCGGAGGTGTGGCGGGACTTCCCCGCCGAGGCCGCGCTGGCGCTCACCACCACCGCGCACCGCATCCGCCTGGACGGCGTCGACCTGTACTTCCTCGCCAACGACTGGCTGAACCGGCTGCCGGACACCTTCTACCCGCCGTACCAGAGCAAGGGCAGCGACCTGGTCTTCTTCAAGCCCCTGGTCTTCCAGGTGGACGCGGTGCGGTTCCTGCGTACCCGGTTCGGTGACGAGAAGGCGCTCGTCCACGCGCACGAGCCCTACTACCACTATCTGCTGCCCGCGGCGCTGCGCGACGACCCTTCGAAACTGGTCGTGAGCAACGTGCAGAGCAACATGCCCATCGCGAAGAAGGTGTACGAACCCGAGGTGCGGCGGTTGCTCGAACTGCTGGGTGCTCCGCTTCCGGCGCGTGCTCCCGAACCGCCCGTCGCCGCGCCCGCGGCCATGGTCCAGTACCAGCAACTCACCCATCTGCACTACGAGTACGGGCCGGACAACCTCGCCGTCTACGAGCTGACCGCCGACCACTCCGATCTGATCGACTTTCTCTCGCCGGGCCAGCTGGACTTCTACGCCGGTTTCCGTGACACCCCGTTCGAGGATCTCTTCGGACGGCTGCCGATCGCCGACGTGGTGCGTCGCAACGCGCACAAGATGTTCGTCGGCGGCTGCGCCGTCTCGGACCAGTGGCTGGCCTGGGACCCCGCCGGAGTCGACCGCACCGAGGTGCTCGAAGGGCTGGGCCTGGACCCGGACCTGCCGGCCTTCTTCCACAACGCCCGCTACGCCGTCCACCACAAGGGTCAGCTGGAGCTGGTCCGCGCCGTCGACCGGGTGCTGAGCGAGGGACTCGCGGCCAGCTTCGTCATCCGCTGCATCTCCGGCAGCGGCATCGACGACCCGTTCTTCCACGAGGTCGCCGCCCGGCACAAGGGGAGGCTGCACCTGGAGTGGGAACGGGTCCCGGAGCGGCAGGTGTTCGGGTACGCGGCCGCCTCCGACTTCTGCCTGTTCCCCTCCAAGTTCGAGATGGACACGTTCCTCATCGCACAGGGCGAGGCCATGGCCGTCGGCTCGGTGCCGATCGCCACGGACCAGCGGGGCATGGCGCACTTCGGACACGCGGACCCTCCGGACTCCGCCACCGGCTTCGCCGTGAACCGTTCGTTCGCCGAGGACGACGAGTTGCTGGTCGCCGCTCTCGCCGCCCGCATCCGTCAGGCGGCCTCCCTGTGGCGGGAGGAACCCGAGCGGTACCGGGAGCTGGCCCGGCGGGCGTCCGCCGTCGCCCGAGTGTTCACCTGGGCCCACTGCGCCGATCTGCACCTGACGGAGTTCGCCCGGCTGTGGCAGGGCGAACCCCCTCGGCTCGATCCCGAGCTCGCCCTGCGGCACGGCTGGTTCGACCTGGTGGAGGACCCGGCACGCACTGCGGAGGCGGCCCTTGCCCGCGGTGATGTGGACGCCTACGAGCGCCGTGCGCCACTGGACGACGCCGCGGTCCGGCAGTTGTTCGACGCGGCCTGGGCACGCGCCGACTTCGCCGCGTGCGAGCGCGCCGCGGAGCGCGGCCGGCCGGGCGTGATCGGCGCCGACGACCTGACTCGGCTGCGCACGCGCGCCCGCCTCACGCCGGACGGCTCCCTGCTCTACCGGCTCCCGCAGGCGGTCCGGGTCGAGGTCGTGTCGCCGGCCTCCGACAGCGGCCCGCGGGCGCGGCCCGGCGTACGCGCTCTGGAACGCACGGCCCCGGGCACGTTCACGGGTCCGGCACCCGGGCCGGGCGCGCTGCTGCTGCTCACCCTGGACTCCGGTCGCGTGGTCTGGGACGAGGTGCGCCGTGGCTGA	MEPRMHIIETYFECCGFDHTFIQGGTSVYLWNLSKKFAQSGHRVSIVTPAHGRLDDLRTRYEVEDLPYEDAYTLPVPLDPEVWRDFPAEAALALTTTAHRIRLDGVDLYFLANDWLNRLPDTFYPPYQSKGSDLVFFKPLVFQVDAVRFLRTRFGDEKALVHAHEPYYHYLLPAALRDDPSKLVVSNVQSNMPIAKKVYEPEVRRLLELLGAPLPARAPEPPVAAPAAMVQYQQLTHLHYEYGPDNLAVYELTADHSDLIDFLSPGQLDFYAGFRDTPFEDLFGRLPIADVVRRNAHKMFVGGCAVSDQWLAWDPAGVDRTEVLEGLGLDPDLPAFFHNARYAVHHKGQLELVRAVDRVLSEGLAASFVIRCISGSGIDDPFFHEVAARHKGRLHLEWERVPERQVFGYAAASDFCLFPSKFEMDTFLIAQGEAMAVGSVPIATDQRGMAHFGHADPPDSATGFAVNRSFAEDDELLVAALAARIRQAASLWREEPERYRELARRASAVARVFTWAHCADLHLTEFARLWQGEPPRLDPELALRHGWFDLVEDPARTAEAALARGDVDAYERRAPLDDAAVRQLFDAAWARADFAACERAAERGRPGVIGADDLTRLRTRARLTPDGSLLYRLPQAVRVEVVSPASDSGPRARPGVRALERTAPGTFTGPAPGPGALLLLTLDSGRVVWDEVRRG	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDLRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	238.83	gnl|BL_ORD_ID|1621|hsp_num:0	1768			396	633	
BGC0000804.1|Acarviostatin_19 # 27594 # 28658 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.705	BGC0000804.1|Acarviostatin_19 	27594	28658	+	Loose	550	25.409	KPC-93	28.57	3007102	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGGGGCCGCTCGGCACCGGCCGCCTCAAGCCGCTGATCCCCTACGGCGGCGCCTGCCGGCTCATCGACTTCAGCCTCGCCAACGCGCACCGGTCCGGGCTGGGCGAGGTGTTGCTGCTGTCGCAGTTCGAGGAGCGGCAGCTCATGGACGACCTGCACCAGGTGTGGAACGCCCGGCCCGGCCTGCGGGTGCACTTCGGGCCGTACGACTCCGCCTACCGGGACGCGCCCGCCGGCCTCCTTCCACGCCGCCTCCCGCCCCGCTCCGGGGCACCGGAGCGGGGCACGGCCGATGCTCTGATCCGCAAGGCGCCCTACATCTTCGGCCCGGGCACGGAACAGGTGCTCGTGCTGCACGCCGATCACGTCTACCGCTTCGACTACGGCCCTCTCATCGCCTCGCACAGGGCGTCGGGAGCCGCCCTGACCATCGCCTACCAGCGCATCGAGCGACGTTGGGTGCATCTGTTCGGGATGGTCGACTTCGACGCGGACAACCGCCTCACACAGTTCGTCGAGAAGCCCGAGCAACCCACCTCCGACCTGGTGTTCGCCGCGTTCTGCGTCTTCGACGCCGAGGTGCTCCACCGCCACCTCGAACAGCTCGAGGGCACCGACTGGCAGCACGACATCAGCCGCGACGTCATCCCGGCCATGCTCGCCGCCGGCGAGGACATCCGCGGCTACGAAGTGCACGGGCACTGGGCGGACATCGGCACCGTCGAGCGGTACCACCGGGCGCACCTGGCCCTCGCGGACCATCCGCGCGCCGGTCTCCCGGCGGACCGGATGCCGTGCACCGTGCGCCCCGACGTGCGGCGCGCCTGGATCTCCGACTCCCCCGGCGTTCGTTCGTCCTGGGTGCCCCAGGATCTGGTCAACGAGGGGCAGGTGGAACGCAGTGTGATCTTCCCCGCGGTCCGGATCGGTGCGGGCGCCAGGGTGCGTCGCAGTGTCGTCCTTCCGGGTGCCGCTGTGCCCGCGGGCGCCGACATCGATGCGTCGGTCGTTCTGGAGAACGGGACGATCCAGCCCATAGCGCGGACAGAAGGAGTACTGACGTGA	MGPLGTGRLKPLIPYGGACRLIDFSLANAHRSGLGEVLLLSQFEERQLMDDLHQVWNARPGLRVHFGPYDSAYRDAPAGLLPRRLPPRSGAPERGTADALIRKAPYIFGPGTEQVLVLHADHVYRFDYGPLIASHRASGAALTIAYQRIERRWVHLFGMVDFDADNRLTQFVEKPEQPTSDLVFAAFCVFDAEVLHRHLEQLEGTDWQHDISRDVIPAMLAAGEDIRGYEVHGHWADIGTVERYHRAHLALADHPRAGLPADRMPCTVRPDVRRAWISDSPGVRSSWVPQDLVNEGQVERSVIFPAVRIGAGARVRRSVVLPGAAVPAGADIDASVVLENGTIQPIARTEGVLT	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNNRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	118.79	gnl|BL_ORD_ID|4781|hsp_num:0	5776			609	813	
BGC0000804.1|Acarviostatin_20 # 28655 # 29581 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.713	BGC0000804.1|Acarviostatin_20 	28655	29581	+	Loose	1190	26.1794	novA	61.11	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCGTTTCCTCGAGCATGTACGACATCCTGGTGGCGGGCGGGGCCGGTGTGGACACCATCGTCCGGGTGCCCGAACTCAGGGTGCCGCCCGGCGACTCCGTGTTCGTACCACCGGTGCGTGACTACGTGGCTCACACCGGCAACGGCGTCGCCCGCGGCACGCACGCCCTGGGGCTCACCACCAAGTTCATCGACTTCCTCGGCGCCGACGCACAAGGCCACCAGATCCTCGCCGCGTACGCCACGTCCGGGCTCGACTTCAGTCACGTCGTCTCGCCGCACGGCACTCCGCGCGGGGTCAATCTCGTCGACGCGCAGGGGCGGCGCTTCTCCTTCTACGACGGCCGCCATCCGGCCGACCTGCGGCTGCCCCGCGCCTTCTACCTGCCCTTCCTGGAGCGGGCCCGGCACGTGCACCTGTCCATCACGGGCGTCACGCTGGACATGTATGCCGACATCCACCGCCTCGGCGTCCCCTGCTCCACGGACCTGCACGACTGGGACGGTGCCAACCCGCACCACCTGGCCTACGCCGTCGCCTCCGACTACGTCTTCATGAGCGCCGCGGCGGTCCACGAACGTCTCGACGAGGTACTGCGTTCCATCCTGGACCGGGGCCGCGCGCGCCTCGTCGTCGCCACCGACGGGGCAGCCGGCTGCCACGTCCTCGAACGCGGCGACACGAGCGTGCGGCGCTACCCCGCCGTAAGACCGGAGCGTCCCGTCGTGGACAGCAACGGCGCCGGGGACGCGTTCGTGAGCGCGTTCCTGTACGCACTCGCGCAGGGAAGGCCGGTGGCCGACTGCGTGCTCGCCGGATCGGTGTCCGGAGCGTTCGCATGCACGAGCGCGGGCACGCACACCGAGTTCATCGACCGGGACGGGCTGCGGGCGGGCTGTGCGCGCGCCGGGGCCGACGGCTGA	MTVSSSMYDILVAGGAGVDTIVRVPELRVPPGDSVFVPPVRDYVAHTGNGVARGTHALGLTTKFIDFLGADAQGHQILAAYATSGLDFSHVVSPHGTPRGVNLVDAQGRRFSFYDGRHPADLRLPRAFYLPFLERARHVHLSITGVTLDMYADIHRLGVPCSTDLHDWDGANPHHLAYAVASDYVFMSAAAVHERLDEVLRSILDRGRARLVVATDGAAGCHVLERGDTSVRRYPAVRPERPVVDSNGAGDAFVSAFLYALAQGRPVADCVLAGSVSGAFACTSAGTHTEFIDRDGLRAGCARAGADG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	50.08	gnl|BL_ORD_ID|1112|hsp_num:0	1210			1731	1785	novobiocin
BGC0000804.1|Acarviostatin_21 # 29599 # 32682 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.723	BGC0000804.1|Acarviostatin_21 	29599	32682	+	Loose	400	27.335	vanR gene in vanC cluster	28.57	3002922	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGCACATCATCACCTTCTCCTTCGAATGCGGCGGCTTCGACCCACGCCTGATGCGCGGCGGACTGTCTCCACTGGTGTGGCAGCTCTCCCGCCGTTACGCCGCGCAAGGCCACCGCGTCTCGCTGGTCACGCCGGGACACGGGCACGTGGACCGGCTGCGGGCCGCCCACGGCATCGAGGACCTGCCGCACCTCACCCGCACCCGCACGGTGCCTCTGGCGCTGGATCCCGAGGTCTGGGCCTCATGGCCGGCCGACCTGGACGTGGACGTGACGACCACGGTGCACCGGCTGCGTCTGGACGGCGTGGACGTGTACTTCATGTCCAATGCGTATCTCGACCTGCTGCCCGACCGGCTGTATCCGCCACCGGGCGTCGAGGGCAGGGACCTCTCCCACTTCAAGCCGCTGGTGTTCCAGGCCGAGGGACTGCGGTTCGTCCAGGAGTACCTGCGGTCGGAGGACGAACCCGCCGTGGTGCACGCCTTCGAACCCGCCTATCACTACCTCTTGCCCCCGGTTCTCGCCCCCGATCCATTCCTCCACACGGTCAGCACCGTCGCCGCGAATGCCCCGATCGGGCAGAAGGTGTACCGGCCCCAGGTGACGCGGATGCTGAAGCTGTTCGGCGTGGCCGACGTGGACCTGGACGCGCTGGACGGCCCGCCGCCCGAGGAGCGCTCGACACGGGCGGTACTCTCGCGCGCCCTGGCCGGGACCCGGATGCACGTCGAGTACGGCCCCGACCACGTCGGCCTGTTCCCGTTGATAGCCGCCCACGCTGATCTGGTCGACTTCGTGTCGCCGGGACAGCGCGCGTACTACAGCACATTCCGGGACACGCCCGTGCAGGCGCTCTTCGAGACGCTGCCGGTGGCCCGGACGCTGCGGCAGCGCGCCGACCGCGTCATCACCGGTGGCTGCGCCGTCACGGACTCCTGGCTGGCGCGCGACACGACCTCGGTCGACCGGCACCAGGTGCTGCGCCGTCTGGGTATCGATCCGGCACTTCCGGTCTTTTACCACGCGGCGCGCTACGCGGTGCACCACAAGGGCCAGTTGGAACTGATGCGGGCTATCGAGGAACTGCTGGACGACGGAGTGGAGGCCGGGTTCCTGCTCCGCTGCTCCACGGGAGACGGCGCCGCGGCGAACGCGTACTTCCAGTCCGTGGCCGACCGCCACCCCGACCGGCTCCGGCTCGCGTGGGATCTCGCGGACGAGGACACCCTCTTCGAGGAGGCGGCGTGCGCCGACTTCTGCGTCTACCCGTCCAAGTTCGAATTGGACGGCTTCCTCATCGCGCAGGCCGAGGCGATGGCCTGCGGGGCCGTGCCGATCGCCACCGACCAGCACGTCACCCGGCACTTCCGGCACGCTCTGCCGAGCGGACATCCCGAGGCGACGGGCTTCTCGGTGCCCGGCTCGTTCCACGACGACGACCCGGCGCTCGCCCGCGGCCTGGCCGCGCGGATCCGCACGGCGGTCGGTGTCTTCGCCGCGCACGTCGACGGTTCCGACCCCACCTATGCCCGGCTGTCCGCCAACTCGCGCGCCCTGGCCCGGAGGTTCACCTGGGAACGCGCCGCGCGCACCCGGCTGGACGCCTTCGAGGGGCTTCTCCATGGCCGGGTCCGGCCGTTCCCCGTGCGCGAGGCGATCGCGTACGGCTGGTTCGACGACCTGCCCGCGAGCGCCTGGGACCAGCACCCCGAGGAGATCCGGGAGGCGGCGCTCACCCGCGGGGACCTCGGCGCGTGGGAGCGCGCGGGCGGGGCGGTGGACGCGCAGGCGTGTGAACGGCTCTTCGAGGCCGCGTGGCGGGAGGCCGAGTTCACCACCGCGCTGCACAACGCCGTGGTGGCCGGACGCTCCGACCTGACCGCCCGGGTTCACGACCGGGGCACCGTTCGACGTACGGCGAACGGCCGGTGGGAGGTGACGTACCGGCACGAGCACGTGGCTCGGGTGGAGGCCGTGCTGGAAGGTCGGAGGGGCGCTTGCACCGGACCGGACGCCGTCTCGGGCGGCTCCCGGCCGGCCGCGGGCGAGACCGCCGCGGAGGCCCTCGCGTCCGACGAGCCGGTGCCCCCCGGCACCGGCGCCGTGTTCCACGCCCTGTCTCCGCAGGACGGTCGGCCCGGTTCCTTCCGGGCCGTACTCGACGCCGCTCCGGCGGGGCGCGACCTGTCCGTCATGCTCACGCTGGCCTCCGGTCACGTCCGCTGGGACACCCTGCCGCTGCGGCGGCCACCGTTCCGGCTGGTCGCAACCGATCTAGACGGGACCCTGTTGCGTGACGACCTGACCGTCTCTCCACGAACCCGTGCCGCCCTCGCGGCGGTGACCGACGCGGGAGCGCACCACCTCGTGGCCACCGGACGCCCGGCCTCGGCCTGCGCGCACATCCTCGACGCCCTCGGATACCGCGGTCTGGCCGTCTGCGGACAGGGCGCCCAGCTGTACGACGCCGGCTCGCGACGGCTGCTGTCCTCGGCCTCCCTCGGCCGTACGCTCGCACGCCGCGTCGTGGCGGGCGTGGAGGAGAGGCTCGGTCCCGTCGAGCTGGGCGTCGTCACGGCGCCGCCGGACAGCCGGTTCAAGGTGACCGAGGGGTTCGGGCAACGTGTGCGCCACGGCTGGGACGTGACCACCGACCGGGACCTGTTGTGGGACAGTCCCGTCGACAAGCTGATCCTGCACCACCCCGAGGTCGACGAGGACCGGCTGGCCGCGCTCACACAGAGTCTGTTCGGCGACGAGGTGACGGTCGTCCACTCCGTGAAGGGCATGGTGGAGGTGCTGCCGCCGGGTACGACCAAGGCCGCCGGGGTCGAGCGCGCCGCCCGGCTGCTCGGCTGCGCCGCGAGCGACACCATCGCCTTCGGCGACATGCCCAACGACATCCCCCTGCTCACCTGGGCGGCGCACGGCGTCGCCGTGGCCAACGCCCACCCGGCCCTGCTCGCCGCCGCCGACGAGATCGCACCGCCCAACGAAGAGGACGGGGTTGCGGTGGTCCTGGAGCGGCTCTTCACCCCCGGGGCGCAGAACCGCCGCACCCCCTCCGAACGTCACGCATGA	MHIITFSFECGGFDPRLMRGGLSPLVWQLSRRYAAQGHRVSLVTPGHGHVDRLRAAHGIEDLPHLTRTRTVPLALDPEVWASWPADLDVDVTTTVHRLRLDGVDVYFMSNAYLDLLPDRLYPPPGVEGRDLSHFKPLVFQAEGLRFVQEYLRSEDEPAVVHAFEPAYHYLLPPVLAPDPFLHTVSTVAANAPIGQKVYRPQVTRMLKLFGVADVDLDALDGPPPEERSTRAVLSRALAGTRMHVEYGPDHVGLFPLIAAHADLVDFVSPGQRAYYSTFRDTPVQALFETLPVARTLRQRADRVITGGCAVTDSWLARDTTSVDRHQVLRRLGIDPALPVFYHAARYAVHHKGQLELMRAIEELLDDGVEAGFLLRCSTGDGAAANAYFQSVADRHPDRLRLAWDLADEDTLFEEAACADFCVYPSKFELDGFLIAQAEAMACGAVPIATDQHVTRHFRHALPSGHPEATGFSVPGSFHDDDPALARGLAARIRTAVGVFAAHVDGSDPTYARLSANSRALARRFTWERAARTRLDAFEGLLHGRVRPFPVREAIAYGWFDDLPASAWDQHPEEIREAALTRGDLGAWERAGGAVDAQACERLFEAAWREAEFTTALHNAVVAGRSDLTARVHDRGTVRRTANGRWEVTYRHEHVARVEAVLEGRRGACTGPDAVSGGSRPAAGETAAEALASDEPVPPGTGAVFHALSPQDGRPGSFRAVLDAAPAGRDLSVMLTLASGHVRWDTLPLRRPPFRLVATDLDGTLLRDDLTVSPRTRAALAAVTDAGAHHLVATGRPASACAHILDALGYRGLAVCGQGAQLYDAGSRRLLSSASLGRTLARRVVAGVEERLGPVELGVVTAPPDSRFKVTEGFGQRVRHGWDVTTDRDLLWDSPVDKLILHHPEVDEDRLAALTQSLFGDEVTVVHSVKGMVEVLPPGTTKAAGVERAARLLGCAASDTIAFGDMPNDIPLLTWAAHGVAVANAHPALLAAADEIAPPNEEDGVAVVLERLFTPGAQNRRTPSERHA	MSEKIVVVDDEKEIADLVTTFLQNEGFSVQPFYDGTSAIAYIEKEAIDLAVLDVMLPDIDGFQLLQQIRKTHFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNHSTASPTVEEYEKDGLILKINSHQCILYGKEVFLTPIEFKILLYLFEHQGSVVSSETLFEAVWKEKYLDNNNTVMAHIARLREKLHEEPRKPKLIKTVWGVGYIIEK	444.59	gnl|BL_ORD_ID|1500|hsp_num:0	1547			507	681	vancomycin
BGC0000804.1|Acarviostatin_23 # 34800 # 35981 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.689	BGC0000804.1|Acarviostatin_23 	34800	35981	+	Loose	700	28.4906	mgtA	37.84	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGTCAGGCCAGGTTCTTGCCCCGGTCGAGCCGGGCGTGCGCGAGGACGCCACCGGCTTCGACCTGCTGGCGCCCGAGGGCACCGCCTACCGCGTGGACCTCACCACAGGGGTGTTCGACCAGGAGAATCCGCTCCTCGCGCGCGCACTCATGGGCCGCAGGGTCGTCGCATTCGTCAGCCCCACGATCGAGGGACTGCACGGTGACCGGCTGCGCGCCTATCTCAACGCCCATGTCGATCCGGGGGACTGGAGTGTCCACACGCTGCGGACCGGCGAGCAGCACAAGACGCTCGCCGCCGCGGAGGACGTCTGCGCCACCGCCAAGGCCGCCGGACTCGACCGTCATGGGGTGATGCTGGCGGTGGGCGGCGGAATAGTCGCAGACGTCGTCGGCTTCGCCGCGTCCATGTACGCGCGCGGTGTCCGCTACGTCAAGGTCAACACGACGCTGGTGGGGCAGGTGGACGTCGGTGTCGGTGTGAAGACCGGTGTCAACGCCCTGCGCACGAAGAACATGCTGGGTGCCTACCACCCGGCTCACGCCTCCATCAATGATCCCGCGTTCCTCACCACGCTGCCCCCGCGTGAGATCCGCTGCGGACTCGCGGAGATCGTGAAGATGGCGGTGATCCTGGACGAGGAGCTGCTGCGGACCCTTGAGGATCACCCGGACGTCTTCCTCGGCCGGCCGTCCGCCGACGGCCGGCTGGAGGAGTATGTGCTGCGGACGTCGATGCGCCTGATGATGGAGGAGCTCTGCCCGAATCTCCGCGAGCACGAGCTGGCGCGCCTCGTCGACTTCGGGCACACCTTCAGTCCGGTGATCGAGACGGCCGGCAACCACCGCCTCGAGCACGGGGAGGCGGTCGCCGTCGACATGGCCCTCTCGGCACACATCGCACGGCTGCTCGGGCTGGCGGACGCGGACACGTGCGAGCGGATCGTGCGCCTGCTGCGGCGCATCGGGCTTCCGGTCTTCGACACCCTCACCTGCACACCCGAACTGATGAGCCATGCGTTGCGGGCATCCTGGGAGCGGCGCGGGCGCAAGCTGCACCTGGTCGTGCCGACGGCACCGGGCAAGGCGACGTTTGTCGAAGAGCTGGGGGACGTCCCCGAGTCGTTGCTGCGCACGGCTCTGTCAGCGCTGGCGCGGGATACGGAGGGGCACCATGTCTGA	MSGQVLAPVEPGVREDATGFDLLAPEGTAYRVDLTTGVFDQENPLLARALMGRRVVAFVSPTIEGLHGDRLRAYLNAHVDPGDWSVHTLRTGEQHKTLAAAEDVCATAKAAGLDRHGVMLAVGGGIVADVVGFAASMYARGVRYVKVNTTLVGQVDVGVGVKTGVNALRTKNMLGAYHPAHASINDPAFLTTLPPREIRCGLAEIVKMAVILDEELLRTLEDHPDVFLGRPSADGRLEEYVLRTSMRLMMEELCPNLREHELARLVDFGHTFSPVIETAGNHRLEHGEAVAVDMALSAHIARLLGLADADTCERIVRLLRRIGLPVFDTLTCTPELMSHALRASWERRGRKLHLVVPTAPGKATFVEELGDVPESLLRTALSALARDTEGHHV	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	94.02	gnl|BL_ORD_ID|2293|hsp_num:0	515			501	603	erythromycin; tylosin; azithromycin; methymycin
BGC0000804.1|Acarviostatin_24 # 35974 # 36390 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.731	BGC0000804.1|Acarviostatin_24 	35974	36390	+	Loose	500	24.2534	OXA-783	50.0	3005986	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCTGAGGCCGTGGACGGCGGGGCGGTGCGCAATCTGCGCGAACTGTTCGCGCCCAAGGAACACGACCACGGTGGCCTCGGCACCATCCTGGCGCACCGGGTCTACGCCCGTCGGAGCGGGCGGCGCGGGGCCGAGTTCGTCGATCTGGCCGTACTGCCGCCCGGCACCTCGATCGGCCGGCACCGGCACGGCGCCGACCGGGAGACGTATGTCGTACTCGACGGCAGCGGGTTGATGTTCCGGGACGGCGAGCACTTCCCGGTCGGCGCGGGCGATGTGATCGCCAATCGCCCGTTCGGCGAGCACGGCCTCGTCAACGACGGCCCGGGGGATCTGCGACTGCTCGTGTTCGAGGAGCCGGAGGCGGCGCGGCCGCGCACCTCCCCCGCCGCGTCCGGGGAGGCGACGGCGTGA	MSEAVDGGAVRNLRELFAPKEHDHGGLGTILAHRVYARRSGRRGAEFVDLAVLPPGTSIGRHRHGADRETYVVLDGSGLMFRDGEHFPVGAGDVIANRPFGEHGLVNDGPGDLRLLVFEEPEAARPRTSPAASGEATA	MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTFKIFNALIALDNGVVKNIKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKHIKNIKIREELLEKYLAIITN	55.42	gnl|BL_ORD_ID|4021|hsp_num:0	5091			201	243	cloxacillin; oxacillin; cefalotin
BGC0000804.1|Acarviostatin_26 # 37436 # 38410 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.724	BGC0000804.1|Acarviostatin_26 	37436	38410	+	Loose	525	30.4166	DHT2-1	37.1	3006872	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	DHT2 beta-lactamase	ATGAGCACCGTCCTGGTGATAGGCAGCGGCTTCGTCGGTACCGGCATCGCCCGGCATCTCGCAGCCCACGGGCACACCGTCACCCTGGCGTCGCGCGGCCGGCCCTCAACGTCGCCCACGACGTACGGGGCACGCTGGGCGGCGCTGGACGCCACCGTCCCCGAGGCGTGCGACAGGCTTCTGACCCGACTGCGTCCCGACGGCGTGGTCCTGGTGCACGGCCCGTCCGACGTGACCTGGTGCGAGGAGCATCCGGGTGAGGCCGAGCAGGCTCACGCAGCGGTAGCGGGCAACGTGGCATCCCTGGCCCCGGGGGCCCGTGTCGTGCTCATCTCCACGGACAACGTCTTCGACGGCTCCTTGCCGCACAACACCGAGTCCACGCCGGTACGGCCCGCGAACGCATACGGCCGCGCCAAGCTCCGTGCCGAGCAGATCCTGCTGGCCACGGCGGCCGACGCCGTGGTGCTGCGCGTGAGCCTCGTCTACGGCCACGAGCCGGCGGGCGCGGGGAAGTGGCTGAACTTCTTCGCGTCCTGCGCTCATCAACTGTTGCTGGGTGAAGCGGTGCACGCGCCCGACGACCATTGGACGACCCCGGTGACCGTCTCCGACGTGGCCCGGGTCACCGCCTCCGTGCTCTTCGCCCCTGCCCCGCTGCCCGAGGTCCTCCACCTCGGCGGTCCGGACCGGGTCACCCGGGCCGAGTGGGCGCTGACGATCGCCGACCTGCTGGGCGCGCCGCGGAGGTTGGTGGTCCCGGTCCCGAAGGCCGCGACGCGGTACGCCTCCCGGCCCGAGAACGCGTGTCTGACAAGCACGTCGCTGCCCGGCCTGCTCGGTCTGATCCCGGTCGACGGTGTCGCCGCCGGGGCGCGAAAGCTCGTCACCGCTTTCACGGGGCGCCACGCGATCAGCCGGACACCTCCGGGGACAGGGCCGGTGTCGACGGAACCGGACCGGGAACGCGGGTGA	MSTVLVIGSGFVGTGIARHLAAHGHTVTLASRGRPSTSPTTYGARWAALDATVPEACDRLLTRLRPDGVVLVHGPSDVTWCEEHPGEAEQAHAAVAGNVASLAPGARVVLISTDNVFDGSLPHNTESTPVRPANAYGRAKLRAEQILLATAADAVVLRVSLVYGHEPAGAGKWLNFFASCAHQLLLGEAVHAPDDHWTTPVTVSDVARVTASVLFAPAPLPEVLHLGGPDRVTRAEWALTIADLLGAPRRLVVPVPKAATRYASRPENACLTSTSLPGLLGLIPVDGVAAGARKLVTAFTGRHAISRTPPGTGPVSTEPDRERG	MSSIVRGVRAAVVASAISLAAAFACLPLAAADATREPVLPQSGRYEVPDSWRQPIAPVRIADHTWYIGTENLSAVLVTTPQGAVLIDGGMPQAADMLLQRMRDVGIAPGDLRWILVSHAHADHAGPVAKVKRATGARIAANAESAAMLARGGTDDIHFGDDITFPPAQADRLLQDDEVVQVGGIALTGHVTPGHTPGSTSWTWTDTKDGKPVRIAYADSLSAPGYKLIGNPRMPRIVEMYEATFAKVRALPCDLLLTPHPDASGWTPADAANPHPSPKTCAAYADEMEAKFDAELAKQRAAK	107.28	gnl|BL_ORD_ID|3515|hsp_num:0	4584			255	414	
BGC0000804.1|Acarviostatin_27 # 38349 # 39743 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.718	BGC0000804.1|Acarviostatin_27 	38349	39743	-	Loose	750	76.2554	PAC-1	29.26	3005150	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	PAC beta-lactamase	ATGGCTCCGTTGCCTCAGCCGTCCGCCGATCCCACGGCCCAACCGATGGGCGGAACCGGGAAGTTGCTCCTGAGCCGGCTCGCTCGCGCCCAAGCCCTGGGGCGGGTCCCGTCCGTCGCGGGCTGTGCCCTGGTCGAAGGACGGACGGCCTGGACCGGCGTCCGCGGACGGGTGGGTGGCGGGTCGCCGACCTTGGACACGCAGTACCGGATCGGGTCGCTCACGAAGTCCTTCACAGCCGTTCTGGTGATGCGGTTGCGGGACCGGGGTGAGCTCAGGACGAACGACCCGCTGGACCGGTATCTGCCGGGCACCGGAATCGGAGACCGCACCCTTGAGCAACTCCTGAGTCACACCGCGGGGTTGACGACCATGACGCCAGGCTGTGACTGGCCGTACAGCGGACAGGGGCCGGCCGATCCGCTGCGGCGCGGGGCCGGGGTTCTCTGCGCGGCGGGGGAGCGCTTCCACTACTCGAATGTCGGGTACGCCCTTCTGGGCGCGGTGATCGAGAGGGTTCGGCAGGAGCCCTGGGCAGACGTGCTGGCCAGGGAGGTTCTCGCCCCACTGGGCATGAGAGGGACGGGCACGGACCCTGGTGCCGAGGCCGCTCCGGGATGGAGCGTGCACCCGTGGGCGCCGACGCTCGTGGCCGAAGAGGTCCAGGACGCCCGCGCCATGGCCGCCGCCGGGGCGCTGTGGTCCACGCCGGCGGACCTCGCCAGGTGGGCGGAGTTCCTCCTGGGCGACTGCGCCGAGGTGCTCCACCCGGACACGCTGGCCGAAATGGCCGAACCGACCCGGCTGTCCGCCCACGAGGACGAGCCCGGCGCCGGATTCGGACTGGGACTGCAGGCGGTACGGCACCAGGGACGCACTCTGATCGGACACCCCGGCGGCATACCGGGATTCCTGGCCACGATCTGGGTGGACCGAGAACGCCGGACGGGGGCAGTGATCGTCGGCAACGCCAGCACCGGGCTGAGCCCGAGCCGGGCCCTGGAACTGCTCGACATCGTGGGTGAGCAGACGCTGCCCCTGCCCGACGAGTGGGCGCCGCAAAACCTGCCGCCCCACCTTCTGGACCTCACGGGCTACTGGTACCAGGGCCCGCGTCCGCACGCCATCCAGATGGAGGCGGACGGCAGCGTGCTGCTGCAACCGGTGAGCACCCGCACCAAGCCTTCCCGCTTCCGCGCTCCGGCCAGCCGGTTCGGTACCACTCCGCAGGGCGGTCTGACCGGACTGGACGGCGCGTACGTGGGAGAGGAACTGCGGGTGCTCCGGGATCAGGACGGGCGGCCGGCGGCCCTCGAGCTCACCGGTGCCCGCTTCACCCGCGTTCCCGGTCCGGTTCCGTCGACACCGGCCCTGTCCCCGGAGGTGTCCGGCTGA	MAPLPQPSADPTAQPMGGTGKLLLSRLARAQALGRVPSVAGCALVEGRTAWTGVRGRVGGGSPTLDTQYRIGSLTKSFTAVLVMRLRDRGELRTNDPLDRYLPGTGIGDRTLEQLLSHTAGLTTMTPGCDWPYSGQGPADPLRRGAGVLCAAGERFHYSNVGYALLGAVIERVRQEPWADVLAREVLAPLGMRGTGTDPGAEAAPGWSVHPWAPTLVAEEVQDARAMAAAGALWSTPADLARWAEFLLGDCAEVLHPDTLAEMAEPTRLSAHEDEPGAGFGLGLQAVRHQGRTLIGHPGGIPGFLATIWVDRERRTGAVIVGNASTGLSPSRALELLDIVGEQTLPLPDEWAPQNLPPHLLDLTGYWYQGPRPHAIQMEADGSVLLQPVSTRTKPSRFRAPASRFGTTPQGGLTGLDGAYVGEELRVLRDQDGRPAALELTGARFTRVPGPVPSTPALSPEVSG	MRCNKNVLSVVLLGALSLSAGNAFGQVSQADVDAVIRPLMSKYKIPGMAVALSVDGQHTFYNYGVASKATGQAVTPTTLFEIGSLSKTFTATLASYAQGQGKLQWSDQASHYLPSLKGSAFDRVTLLNLATHTSGMPLFVPDEVTNQEQLMAWYQAWQPTAPIGSQRVYSNLGIGMLGLITAQSLQKPFSEAMEQDLLAPLGMKHSWVKVPENQMAEYAQGYNKLDEPVRVTPGPPDAEAYGLKSSSADLLRWLDLNMAITPPSPAWQQAITETHKGYYQTGEFTQALIWEYYPWPTTKETLLAGNSSERIMKGLGAKPLTPPQAGPEQAWYNKTGSTNGFSTYAVFIPGQKTALILLANKWYPNDARIEAAYELVQRLKK	121.78	gnl|BL_ORD_ID|2857|hsp_num:0	3875			129	768	
